University of South Florida

Scholar Commons
Graduate Theses and Dissertations

Graduate School

5-5-2008

Etiological Characterization of Emergency
Department Acute Poisoning
Abdmalek S. Khlifi
University of South Florida

Follow this and additional works at: https://scholarcommons.usf.edu/etd
Part of the American Studies Commons
Scholar Commons Citation
Khlifi, Abdmalek S., "Etiological Characterization of Emergency Department Acute Poisoning" (2008). Graduate Theses and
Dissertations.
https://scholarcommons.usf.edu/etd/330

This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in
Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.

Etiological Characterization of Emergency Department Acute Poisoning

by

Abdmalek S. Khlifi, M.D.

A dissertation submitted in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy
Department of Environmental and Occupational Health
College of Public Health
University of South Florida

Major Professor: Raymond D. Harbison, Ph.D.
Rony Francois, Ph.D.
Jay Wolfson, Dr. P.H
Steve Morris III, M.D.

Date of Approval:
May 5, 2008

Keywords: asthma, heroin abuse, cocaine abuse, suicide, co morbidity, depression,
psychosis, hospital cost, length of stay
© Copyright 2008 , Abdmalek Khlifi

DEDICATION

I dedicate this dissertation to my family and to my friends. A special feeling of gratitude to
my loving parents, Bacha & Fajrah Khlifi for their patience and their sacrifice and support.
To my son Skandar and to my Wife, for their patience
& support throughout all these long years of school
To my sisters Dalila, Sabah, Mounjia, Yamina
&
to my brothers Rchid, Noureddine Faisal and Houcine.
I also dedicate this dissertation in memory of my mother in law who died of a liver failure
and never had access to a transplant.
To my many friends who have always supported me throughout and I will always appreciate
all they have done for me.
I also dedicate this work to two special friends Dr. Carney & Mr. M. Labidi.

ACKNOWLEDGMENTS

I would like to thank all the people who helped on this research. First, I wish to thank
my advisor, Dr. Raymond Harbison for all his guidance, encouragement, support, and
patience. His sincere interests in science and education have been a great inspiration to me.
Also, I would like to thank my committee members Dr. Francois, Rony, Dr. Jay Wolfson and
Dr Steve Morris for accepting to be members of my committee and for their continuous
availability, help and support.
Additionally, I would like to acknowledge Dr. Leslie Zun who helped and supported
me implementing this project. I also would like to acknowledge all his research tem and
fellows that participated generously on this project and were very helpful in its completion.
I must acknowledge the many friends, colleagues, students, IMGs, IRB committee
members’ teachers, librarians who assisted, approved, advised, reviewed, discussed,
suggested and supported my research.

TABLE OF CONTENTS

LIST OF TABLES

i

LIST OF FIGURES

ii

LIST OF ABBREVIATIONS

iii

ABSTRACT

iv

INTRODUCTION

1

STUDY AIMS AND OBJECTIVES

3

BACKGROUND AND LITERATURE REVIEW

4

STUDY HYPOTHESIS

15

MATERIALS AND METHODS

16

1.0. Design of The Study

16

2.0.Data Collection and Material Studied

17

3.0.Definition of Variables

19

4.0.Data Analysis

21

RESULTS

22

1.0. Demographic Characterization

22

1.1. Age and Gender

22

1.2. Race and Marital Status

24

1.3. Employment and Insurance Coverage

25

1.4. Mode of Arrival

27

1.5. Chief Complaint

28

1.6. Vitals on Admission

29

1.6.1. Temperature on Admission

29

1.6.2. Heart Rate

30

1.6.3. Respiratory Rate

30

i

2.0.

3.0.

1.6.4. Systolic Blood Pressure

31

1.6.5. Diastolic Blood Pressure

31

1.6.6. Glasgow Score

32

Poisoning Agents

32

2.1. Poisoning and Medical History

34

2.2.Relationship of Poisoning to Smoking and Alcohol Abuse

34

Poisoning Co-morbidity

34

3.1. Personal Medical History & Diabetes Mellitus

34

3.2. Personal Medical History of Hypertension

36

3.3. PMH of Cardio Vascular Diseases

37

3.4. Personal Medical History of Arthritis

37

3.5. Personal Medical History of Malignancy

37

3.6. Personal Medical History of Asthma

37

3.7. Personal Medical History of Depression

41

3.8. Personal Medical History of Psychosis

43

3.9. Personal Medical History of Other Mental Illnesses

45

3.10. History of Smoking

45

3.11. History of Alcohol

48

3.12. Intake History of Recreational Drug Use

50

4.0. Analysis of ED Management & Final Outcome

51

4.1. Initial Site Management Effect on The Outcome

51

4.2. Poisoning Final Outcome

52

4.3. Correlation of Outcome and Site Management

54

4.4. Prior History of Poisoning

54

4.5. Follow Up

55

4.6. Final Disposition

55

5.0. Analysis of Correlation

58

5.1. Depression Correlations

59

5.2. Psychotic Disorders Correlations

61

5.3. Heroin Poisoning Correlations

61

ii

5.4. Cocaine Poisoning Correlations
6.0. Prediction Analysis

62
64

DISCUSSION

66

CONCLUSION

74

REFERENCES

77

FINANCIAL DISCLOSURE

88

APPENDICES

89

Appendix A: Models Calculation Tables
ABOUT THE AUTHOR

90
End Page

iii

LIST OF TABLES

Table 1

Summary Table Diabetes, Asthma & hypertension

40

Table 2

Summary list of Depression correlations

60

Table 3

Summary list of psychosis correlations

61

Table 4

Heroin Significant correlations

62

Table 5

Cocaine significant correlations

63

Table 6

Model Summary for Poisoning Final Outcome

90

Table 7

Stepwise Regression Model for Suicidal predictability

92

Table 8

Heroin poisoning Predictors Model Summary

93

Table 9

Asthma Model Predictors

95

Table 10

Asthma Regression Model Summary

96

iv

LIST OF FIGURES

Figure 1

Poisoning Age Distribution

22

Figure 2

Poisoning Distribution by Gender

23

Figure 3

Distribution of Poisoning by Gender & by Age

24

Figure 4

Poisoning Race Distribution by Age

24

Figure 5

Marital Status Distribution by Age

25

Figure 6

Poisoning by Employment Status

26

Figure 7

Poisoning Employment Distribution by Age

26

Figure 8

Mode of Arrival

27

Figure 9

Chief Complaint

29

Figure 10

Temperature on Admission

29

Figure 11

Pulse on Admission

30

Figure 12

Respiratory Rate on Admission

30

Figure 13

Systolic Blood Pressures on Admission

31

Figure 14

Diastolic Blood Pressure on Admission

31

Figure 15

ED Poisoning Exposure

32

Figure 16

Overall Route of Exposure

33

Figure 17

PMH of Diabetes and Hypertension

35

v

Figure 18

PMH of Hypertension and Cardio Vascular Diseases

36

Figure 19

Smoking & Regular Drinking by Asthma Co-morbidity

38

Figure 20

Depression & Psychosis Co-morbidity by age

43

Figure 21

Smoking and Alcohol Co-morbidity by Age

46

Figure 22

History illicit drug abuse by Co-morbidity

50

Figure 23

Major Outcome & Final Disposition by Initial Management Site

52

Figure 24

Admission rates by co-morbidity

53

Figure 25

Documented Prior History of Poisoning

54

Figure 26

Percent of After Hospitalization Follow Up

55

Figure 27

Final Disposition Distribution

56

Figure 28

Disposition by ER management time

57

vi

LIST OF ABBREVIATIONS

LOS: Length of stay
CU: Cocaine Users
DA: Drug Abuse
IDU: Illicit Drug Use
HU: Heroin Users
HCU: Heroin & Cocaine Users
PCP: Primary Care Physician
MDU: Multiple Drug Users
Binned: Grouped
UK: Unknown or missing
AA: African American
ED: Emergency Department
Hisp: Hispanic
PMH: Personal Medical History
CVD: cardio vascular diseases
ED: Emergency Department

vii

ETIOLOGICAL CHARACTERIZATION OF EMERGENCY DEPARTEMENT ACUTE
POISONING
AbdMalek S. Khlifi, M.D.
ABSTRACT

Poisoning is frequently associated with psychological and physiological comorbidities that can be assessed in order to improve patients’ management and reduce
cost. The primary objective of this study is to conduct a review of emergency department
(ED) poisonings to characterize its demographics and assess associated co-morbidities.
The second objective is to explore correlation between personal history of diseases and
poisonings. Predictors for poisonings and its outcomes were investigated and risk factors
for suicidal poisoning and how it relates to mental illnesses were explored. Six hundred
and forty nine cases admitted to ED between 2004 and 2007 were studied. Results indicate
that difference in ethnic background was substantial as poisoning cases were
predominantly African Americans (79.9%) between 36-45 years old with a male to female
ratio of 1.3. Intentional illicit drug overdose was the greatest risk factor for ED poisonings,
and among the 649 cases, heroin overdose was the most common cause of poisoning at
35.4% (n=230), cocaine overdose at 31.7% (n=206), heroin and cocaine overdose at 4.3%
(n=28), multiple drug poisoning at 5.5% (n=36), and antidepressant/antipsychotic
poisoning at 6% (n=39). A significant correlation between heroin poisonings and asthma

viii

(F=20.29, DF=1, p= .0001) was found, as well as between cocaine poisoning and
hypertension (F=33.34, DF=1, p=.0001), and cocaine poisoning and cardiovascular
diseases (F=35.34, DF=1, p=.0001). Another significant finding is the change in the
pattern of the route of illicit drug use from injection to inhalation; it is thought this may
reduce the rate of HIV and Hepatitis transmission via hypodermic needles among illicit
drug users. As well, inhalation and insufflation may be risk factors that aggravate
preexisting asthma. Mental illnesses, chiefly depression, remain one of the greatest risk
factors for suicidal poisoning beside age, Hispanic race, gender, ingestion route and
unemployment. This study provides supporting evidence that poisoning, particularly
deliberate poisoning with illicit drugs remains a serious issue that significantly aggravates
co-morbidities and raises treatment cost by increasing both the rate of hospitalization and
hospital length of stay (LOS). Pragmatic guidelines and innovations in reducing heroin
and cocaine abuse in these patients may lessen the severity of diseases and reduce its
burden on the healthcare system and on society.

ix

INTRODUCTION

Poisonings from intentional substance abuse, as well as from unintentional toxic
exposures, remain a significant health concern for hospital emergency departments. It is
estimated that there are more than four million incidents of poisoning in the United States
each year. The Institute of Medicine has recently identified that poisonings are the
second leading cause of injury-related mortality, with an estimated cost of over $12.6
billion annually (Koplan et al. 1993).
The majority of poisonings, particularly minor and moderate cases, are commonly
managed at home with the direction of local poison centers via telephone. While the
surveillance of moderate poisonings is well documented in this way, severe cases of
poisoning that necessitate an emergency department (ED) admission are often not
reported to poison control centers, and subsequently, the magnitude and trends of severe
poisonings is unknown, and can only be analyzed using patient data from hospital
emergency departments. This study is intended to fill these data gaps, to study the
etiological causes of poisonings and to characterize its demographics and trends.
The substances responsible for accidental poisoning and the methods used for
self-poisoning have changed considerably over time (Howton et al. 1997, Townsend et al.
2001). In many countries, especially in Western Europe and North America over the last
two decades, the most common agents taken by adults have been illicit drugs (Byard et al.
2004, Townsend et al. 2001).
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The annual incidence of intentional and unintentional poisoning in developing
countries varies from 0.2 to 9.3 cases per 1,000 population, and continue to increase
annually worldwide (Gulsah & al). The characteristics of poisoning in third world
countries are slightly different from what is seen in the western world. Agricultural
chemicals, particularly pesticides, are still on the top of the list for both intentional and
unintentional poisoning and are still serious public health concerns in these countries.
In the United States, emergency department (ED) visits for attempted suicide and
self-inflicted injury are relatively common, serious, and most frequent among adolescents
and young adults. Self-poisoning is the most common method for suicide. The high
prevalence of psychiatric and substance abuse disorders suggests there is an association
between the two.
Knowledge of condition-specific morbidity and mortality for patients with asthma
as well as other aggravating factors is essential for making critical decisions. Substantive
differences have been reported in terms of the prevalence of drug abuse among asthma
patients; however the etiology and the mechanisms of action for this association have not
been explained.
There is a need, especially for the underserved minority communities that have high
frequencies for certain methods of drug use, to understand the factors involved in
poisoning and how to effectively design prevention programs for the purpose of reducing
their occurrence and adverse outcomes.
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STUDY AIMS AND OBJECTIVES

The objectives of the study are: To conduct a retrospective chart review to
characterize the demographics of acute poisoning of patients that visited or were admitted
to ED (ED poisoning) between December 2004 and May 2007; To identify the most
common substances associated with poisonings and stratify them by route, age, gender,
time of the day and reason for admission. Co-morbidities of mental disorders, asthma,
diabetes, chronic hypertension, cardiovascular diseases, arthritis, cancer, drug abuse and
occupational exposures will also be examined to assess their correlation with ED treated
poisoning.
A cost assessment was also designed to assess the burden of heroin and cocaine
poisoning on asthma patients. Specifically this study will assess the type and route of
poisoning and stratify them by illicit drug, pharmaceutical, chemical, occupational,
industrial or domestic poisonings. This investigation will assess the circumstances of the
poisoning including accidental or intentional suicidal. The rate of hospitalization and the
final outcome of poisoning events will be examined. This study will evaluate the rates of
complications from poisonings as well as the length of stay and the casualty rates if any
have occurred. On site initial management received by patients at home or administered
by patients’ families before arrival to ED and its effect on the final outcome of the case
will be examined in order to estimate which of these factors are most predictive of the
outcome and poisoning final disposition.
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BACKGROUND AND LITERATURE REVIEW

Poison exposure is a significant health concern and it is the third most common
cause of death that occurs at home (Schauben & Spillane, 1991). While the overall true
incidence is unknown, it is estimated by many researchers that there are over four million
poison exposures per year (Litovitz et al. 1995.)
According to the Center for Disease Control and Prevention (CDC), cases of
poisoning are grossly underestimated and a significant number of them never reach the
hospital since many of the minor case are treated at the patient’s home and are never
recorded through poison control centers. Among all deaths due to poisoning, carbon
monoxide intoxication is the most prevalent.
Over 86 percent of all reported poisoning cases were related to accidental exposure,
while suicidal or self poisoning accounted for less than 8% of the total reported
poisonings (Litovitz et al. 1995; Simonsen, 1992). The largest proportion of accidental
poisonings represented events that were preventable. The “Healthy People 2000” report
has called for the importance of the reduction, prevention, and treatment of poisoning
(Litovitz et al. 1994).
In a study conducted in Barcelona, Spain, it was estimated that poisoning
constituted 5.2% of all emergencies. Among poisoning cases reviewed in this study
87.2% were due to heroin related events, 13.1% were due to acute alcohol intoxication
and 6.2% were due to acute medicinal intoxication. During the study period of 3 years,
the authors identified over 233 emergencies involving cocaine. Of these, 55% were
4

female with a mean age of 28.3 years. The authors also reviewed 1,134 patients with
episodes of acute poisonings seemingly related to pharmaceutical drugs. The most
commonly used drug was benzodiazepines at 56.7%, followed by analgesics at 12.6%
and barbiturates at 11.7%. The Barcelona study also identified 1,456 toxicological
emergencies; 62% of these were suicidal attempts, and 12.6% accidental intoxications. It
is important to note that in this study the author has included withdrawal syndrome within
the definition of heroin and cocaine poisoning in his statistics (Monteis Catot et al. 1990).
Drug abusers are more likely to be hospitalized, and 2.3 times more likely to use an
emergency room than non-abusers (Stein et al. 1993). Patients using drugs are frequently
seen in EDs and drugs encountered generally reflect regional and city variation, as drug
obsession sweeps through subcultures. It is now known that there is a tendency for
specific drug subcultures to grow locally around the use of specific agents. The overall
local drug use trends in the United States indicate that cocaine abuse decreased between
1992 and 2002 (Bernstein et al. 2005). On the other hand cocaine abuse decreased in five
states by more than 60% it increased 100% or more in four other states.
A considerable part of emergency care is treating medical complications of
substance abuse, but the actual abuse of drugs is often not addressed in ED (Bernstein et
al. 2005). This lack of interest to identify drug abuse may relate to the fact that
physicians, particularly emergency physicians (EPs), use illicit drugs as often as the
general population (Hughes et al. 1999).
Marijuana is the most commonly used drug in the United States, but leads to less
ED visits than other drugs. Researchers estimated that there were over 2.6 million new
marijuana users in the year of 2001. Over 3.1 million Americans use marijuana daily, and
5

over 14 million of Americans aged 12 and older use marijuana at least once a month
(NIDA 2008). In recent years marijuana has become more potent than of what it was in
the 1970s and 1980s, which resulted in more ED visits among youth, and in 2002,
marijuana became the third most common drug seen in ED. Marijuana use increased by
over than 24% between 2000 and 2002 (Whalen et al. 2006, NIDA 2008)
Another significant increase seen in recent years is the use of non-crack cocaine
among tenth graders, which has risen from 1.1% in 2003 to 1.5% in 2004. The same
study, however, reported that heroin, crack cocaine, hallucinogens, phencyclidine
amphetamine, tranquilizers, sedatives, and methaqualone use remained stable among
youth from 2003 to 2004 (NIDA, 2006). Heroin use remains to be a serious problem in
some regions of the United States. A recent change in the route of use of heroin was
noted, and there is a new practice of mixing heroin and heating it in aluminum foil then
inhaling through a straw, or mixing it with cocaine promoting the significant shift from
heroin injection to heroin inhalation. Heroin abuse is associated with fatal overdose,
spontaneous abortion, and serious infectious diseases like HIV and hepatitis among IV
abusers, and rare cases of spongiform leukoencephalopathy.
Although heroin, cocaine, and marijuana remain the most frequently abused drugs
leading to ED visits, ED visits involving narcotic analgesics increased 153% from 1995
to 2002. The use of drug combinations were involved in 75% of the drug abuse–related
ED visits, and dependence was the underlying factor in these ED visits. In 2003, about
4% and 4.5% of high school seniors reported nonmedical use of oxycodone. These users
have a higher economic status. (D'Onofrio Gail et al, 2006).
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The Substance Abuse and Mental Health Services Administration estimates that in
2003, 6.3 million Americans abused prescription drugs. Most abused pain relievers (4.7
million); others abused tranquilizers (1.8 million), stimulants (1.2 million), and sedatives
(0.3 million). Nonmedical use of oxycodone increased from 11.8 million users in 2002 to
13.7 million users in 2003. (Volkow, NIDA 2004/2005).
A shift to smoking has occurred for the use of stimulants and this route has
increased from 12% in 1992 to over 50% in 2002. In 2003, an estimated 378 thousand
drug users met the diagnostic criteria for stimulant dependence in the United States
(NIDA, 2006).
Cocaine is a strong central nervous system stimulant. It can result in acute
myocardial infarction or stroke and sudden death. Cardiac complications, such as cardiac
arrest and seizures are generally the main causes of cocaine-related deaths. The use of
cocaine occurs in a binge pattern, during which the drug is repeatedly taken at high doses.
If cocaine is mixed with alcohol, the product is cocaethylene intensifies cocaine’s
euphoric effects, but also increases the risk of sudden death. The wanted effect of cocaine
is usually the resulting euphoria that lasts 15 to 20 minutes if snorted and 5 to 10 minutes
when smoked. In addition to euphoria, cocaine can raise blood pressure, cause
tachycardia, constrict vessels, and dilate pupils.
The wanted effect of heroin users is euphoria, (also called “rush”); heroin can also
cause flushing of the skin, and dry mouth. When tolerance develops, heroin users become
obliged to use higher doses in order to achieve the same wanted effect.
Opioid overdose causes respiratory depression that can be reversed by Naloxone.
The onset, severity, and duration of withdrawal symptoms depend on the opioid abused
7

and the extent of dependence. Sixty-two percent of primary heroin admissions reported
injection as the route of administration, 33% reported inhalation, and 3% reported
smoking. Maintenance treatment for heroin addicts involves daily oral synthetic opiate
administration usually methadone. Buprenorphine is also a medication now available for
treating addiction to opiates.
Treatment of teenagers for marijuana dependence and abuse has increased 142%
since 1992. Marijuana is known as a recreational drug, particularly to teens. Teenagers
are three times more likely to be treated for marijuana than for alcohol and six times more
likely to be in treatment for marijuana than for all other drugs combined (Stephens et al.
2000).
The proportion of admissions for abuse of stimulants increased from 1% to 7%
between 1992 and 2002. Abuse of prescription medications has increased in all segments
of the population. In 2003, about 4% to 4.5% of high school seniors reported nonmedical
use of oxycodone (NIDA, 2006).
“Club drugs” are sometimes preferred over other types of drugs like marijuana and
heroin or methamphetamine because some users see them as social interaction enhancers.
Club drugs such as GHB, flunitrazepam or ketamine are taken in combination, or with
alcohol. They are easy to acquire and they are generally favored over marijuana, lysergic
acid diethylamide, methamphetamine, and opiates (Gahlinger, 2004).
Hallucinogens are less commonly used. Most users of lysergic acid diethylamide
voluntarily decrease or stop its use over time. Lysergic acid diethylamide is not
considered addictive (NIDA, 2006).
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Gulsah et al. 2005 reviewed the frequency and mortality risk factors of acute adult
poisoning in Adana, Turkey from 1997 to 2002 and included 2,229 adult patients. The
authors reported that 1.6% of their emergency cases were poisoned and the majority of
these poisoned cases were attempted suicides (76.4%). Drugs were the most common
(59.0%) poison used, and pesticides were the second (26.4%) most common substance
encountered. Among drugs, psychoactive were the most common (35.5 %).
The number of drug abusers is increasing across the U.S. at an alarming rate,
though many of the related deaths are preventable. According to a recent report
conducted in Multnomah County, Oregon, heroin alone was implicated in over 3805
deaths between 1993 and 1999 (Koplan et al., 2000).
Heroin has greatly increased in popularity in recent years. For many young people,
it is now the drug of choice, with a dose or "hit" available on some streets for the same
price as a pint of beer.
The low price indicates there is a significant supply of the drug. Low and middle
class youth seem to be particularly lured by the drug; and the most prevalent route of
administration has also shifted since the early 1990s to sniffing and snorting over
injecting the drug. The drug has been widely available, and heroin on the street now is of
a higher purity and better quality than before.
The association of drug abuse co-morbidity, particularly cocaine and asthma, has
been reported in few articles. A study conducted in Bronx, NY, where the author studied
the occurrence of new onset bronchospasm or recrudescence of asthma, established a
correlation between cocaine use and new onset asthma. (Osborn & Al. 1997).
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The evidence of heroin’s effect on the respiratory system, particularly the lungs, has
been studied by Steensen et al in 1993 who established a direct relationship between
heroin abuse and pulmonary edema. This research did not clearly describe the mechanism
of action but it was concluded that one possibility is the increased pulmonary
permeability of the lung capillaries in response to the exposure. In 2004 Marby et al
found a pattern of heroin overdose-induced pulmonary edema.
In the early twenty first century, cocaine and heroin abuse was studied, and were
found to increase the rate of intubations and hospital utilization in patients with acute
asthma exacerbation (Levine et al. 2005).
When heroin was first discovered to be correlated to patients with life threatening
asthma in the early 1990s from a limited set of cases, it was initially thought that this was
a novel phenomenon that did not exist before, and was related to the change in the pattern
of the drug exposure from injection to inhalation (Krantz et al, 2003). For the purpose of
verifying if this is a new phenomenon, a limited retrospective study was conducted which
concluded that this relationship has existed prior to the 1990s.
In reviewing the literature however, it was found that this model of correlation was
also described in 1988 when an unexplained exacerbation of asthma in 3 cases that
required intubations was linked to heroin use (Hughes et al.).
Heroin insufflation was then studied by Krantz at al. 2002 to further investigate
this theory and attempted to demonstrate that the insufflation of heroin functioned as a
trigger for patients with life threatening asthma. In this study, the authors reported that of
the total 104 patients admitted to ICU, most patients were not significantly different in
mean age or sex between groups of patients with diabetic ketoacidosis (DKA) and
10

asthma. Although the racial distribution did differ in that the DKA group had more
Hispanics than whites in the asthma group. However compared to ICU admissions with
DKA, asthmatic patients reported higher prevalence of heroin use (41.3% vs. 12.5%).
Asthmatics were also more likely to report cocaine use, but the difference between the
two groups was not significant.
Levine et al. identified 152 ICU patients of which he found 27.6% used cocaine
without heroin (and they were classified as cocaine users) and 30.9 % used heroin with or
without cocaine (and were classified heroin users). Cocaine users had longer lengths of
stay than non-users (3.4 vs, 2.5 days p<0.049) and were more frequently hospitalized and
intubated. Heroin users were intubated more frequently than non-users. Neither hospital
stay nor percentage of ICU admissions was significant (Levine et al. 2005). The author
showed that both cocaine and heroin might have induced asthma exacerbation by
multiple effects on the bronchus, such as the morphine bronchoconstrictive effect (a
metabolite of heroin through deregulation of mast cells and subsequent release of
inflammatory mediators particularly histamine) (Withington et al. 1993).
In a case series reported in late 2005, Cygan et al. described 5 cases of status
asthmatics that were induced by heroin inhalation. Though he hypothesized that the cases
were directly triggered by the inhalation of the drug, the author was unable to establish a
single mechanism of how heroin triggered asthma.
There are several suggestions about the mechanism of action of heroin related
asthma effects, but pulmonary mast cell degranulation secondary to heroin may be very
plausible as indicated by an experiment that used intradermal and IV morphine and
synthetic opiate administration, resulting in a stimulation of mast cells to release
11

histamine. This release of histamine is a direct pharmacologic mechanism independent of
opiate receptors. However, none of the studies that suggest heroin acts as a trigger for
asthma have reported that the exacerbation occurred at the time of the first use. This
makes the histamine release theory very unlikely though it seems very appealing. Unless
the heroin sensitization period is extremely long, which is contrary to what is currently
known about immunological sensitization. Association of other factors that are receptor
independent might be also possible. The controversy regarding this issue remains, given
the fact that opioid receptor action is thought to result in reduction of bronchoconstriction
by blocking the cholinergic factor in bronchoconstriction.
Asthma is a multifactorial disease influenced by genetic and environmental factors
(Matthis et al. 2006). A recent study have revealed the involvement of some receptors
regulated by inherited genes in the pathogenesis of asthma that could predispose some
families or ethnic groups to higher risk for acquiring asthma (Lachheb et al. 2008). In the
past decade, several loci and over 1100 genes have been found to be associated with the
disease in some populations. Among these loci, region 12q13-24 has been implicated in
asthma etiology in multiple populations, suggesting that it harbors one or more asthma
susceptibility genes (Balaci et al. 2007). On the other hand there are significant and
distinct changes in the profile of gene expression in the human nucleus associated with
cocaine and heroin abuse (Albertson et al. 2006) and several gene variants have been also
detected and inferred to contribute to heroin abuse and addiction. For most of these
genes, however, the relationship to the pathophysiology of asthma remains speculative,
and none appear to be directly involved in the activation of airway inflammatory
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processes or allergies, or explain fully all the aspects of the complex mechanism of
addiction and abuse of heroin.
Several studies suggest the presence of a relationship between mental illnesses and
poisoning for self-harm. Attempted suicide is known to be risk factor for committed
suicide, and certain characteristics were seen among those who commit suicides such as
having made previous suicide attempts, or having a family member who has attempted
suicide. One of the studies has shown that attempted suicide is most closely related to
depression. But the study concluded that patients with depression were significantly more
often aged, male, married, and used methods other than poisoning by solids or liquids
compared with patients with other mental disorders (Ichimura et al. 2005).
Depression is the disease most often implicated in suicide. In many countries, there
has been a consistent increase in suicides among adolescents and young adults, as well as
a decrease in suicides among women. The management of depression includes
antidepressant medication. However, appropriate antidepressant prescribing is a very
important factor in terms of preventing fatal antidepressant overdose. The actual risk of
suicide in patients prescribed an antidepressant may be up to 10 times greater than for
others. The likelihood for serious and potentially fatal poisoning following overdose
differs considerably among the drugs available. Most deaths from overdose are
attributable to tricyclic antidepressants (Henry 1996).
Howton, in a meta-analysis focused on patients with bipolar disorder in which
suicide (13 studies) or attempted suicide (23 studies) was reported as an outcome. The
study identified the main risk factors for suicide as previous suicide attempt and
hopelessness. The main risk factors for nonfatal suicidal behavior included family history
13

of suicide, early onset of bipolar disorder, extent of depressive symptoms, increasing
severity of affective episodes, the presence of mixed affective states, rapid cycling, comorbid Axis I disorders, and abuse of alcohol or drugs. The author concluded that in
patients with bipolar disorders, prevention should include attention to these risk factors in
assessment and treatment, including when deciding whether to initiate treatment aimed
specifically at reducing suicide risk (Hawton, et al. 2005).
According to Nordentoft et al. 2007, who focused their work on the prevention of
suicide in Denmark, where suicide rates have been declining in the last two decades for
all age groups, the decline seems to be largest among females. Their conclusion is that
the decline is mainly due to the focus on psychiatric patients, especially schizophrenic
related disorders and homeless persons. In his study he identified that the most significant
risk factors for suicide are: male gender, young age, short duration of illness, multiple
admissions during the prior year, shorter time since discharge from a healthcare facility,
co-morbid depression, drug abuse, poor compliance with medication and high IQ
(Nordentoft et al. 2007).
Another study conducted in Mexico in 1999 concluded that there were high rates of
suicide related depressive disorders in a predominantly female population. Drug products,
according to the author, were more frequently used than home or work related chemicals.
The mortality related to poison exposure was very high at 27% and 16% with permanent
squeal, though advanced life support and antidote medications were available (Kingsbury
et al. 1999).
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STUDY HYPOTHESES

1- Drug abuse overdose is the greatest risk factor for ED poisoning compared to
the other environmental, occupational or prescription medication drugs.
2- There is a correlation between preexisting history of chronic disease, such as
asthma and intentional poisoning using heroin or cocaine.
3- Mental illness, such as depression and psychotic disorders, are risk factors for
ED poisoning.
4- Illicit drug poisoning is a burden on asthma patients, and it incurs longer
hospital stays and higher hospital costs compared to those who do not present
with a history of illicit drug poisoning.
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METHODS AND MATERIAL

1.0- DESIGN OF THE STUDY
The study population consists of Chicago city residents visiting the Emergency
Department (ED) of the Sinai Hospital between December 2004 and May 2007. The
Sinai System provides virtually all-medical and surgical care in the area and it also
includes a children’s hospital and a rehabilitation center. The hospital is serves the
population 5 miles west of down town. This population is diversified between African
American, Hispanic, white, and Indian ethnicities.
This study is retrospective, and all cases of poisonings were identified through a
search of the electronic records using the International Classification of Disease Ninth
Revision, Clinical Modification (ICD-9-CM). A database of all ED poisoning cases was
compiled from ED electronic records. Data pertaining to history of chronic disease comorbidities, as well as to poisoning by illicit drugs, pharmaceutical, and chemical agents
was collected.
The poisoning exposure variable described the type of poison, the poisoning
exposure route, and the circumstances of intoxications; (intentional, unintentional or selfpoisoning or attempted suicide). Initial management of the event was also collected to
determine its adequacy and to correlate it to the final outcome and final disposition of the
poisoning cases.

16

Data on the history of prior poisoning was collected in addition to smoking,
alcohol, and illicit drug use. The data collection preprinted sheet included also personal
history of mental illness such as depression, psychosis and anxiety disorders.
Data on the initial management received and follow-up, as well as the outcome of the
event as assessed by the treating physician at the time of transfer or discharge was
collected.
In order to assess hospital cost and the burden of drug abuse on asthma, a follow up
study was designed to collect cost data and assess expenses, including expenses paid by
insurance and by self-payers. Two groups of patients were selected: the first group of 137
patients was selected from the 649 patients initially compiled for poisoning. The second
group was randomly selected from the pool of asthmatics that were not known to have
any abuse history or hospitalization for any drug related event. Age, race, and insurance
coverage data was collected as well as hospital charges, and amounts collected, expenses,
and length of stay for those hospitalized.
2.0. DATA COLLECTION & MATERIAL STUDIED
The data collection was performed according to HIPAA regulations and after
approval by the hospital’s Institutional Review Board (IRB) committee. The system
database was queried for cases of poisoning during the period between December 2004
and May 2007 to generate a list of patients to be enrolled into the study.
Data abstracted from patients’ medical records included age, gender, race, date and
time of the visit, marital status, employment, insurance coverage, chief complaint and
vitals on admission. Information on the patient’s personal medical history of diabetes,
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mellitus, hypertension, cardio-vascular diseases, asthma, arthritis, HIV, hepatitis and
seizure disorders was recorded.
Initial medical management and assessment of the gravity of the case was
recorded and then weighed against the final outcome in order to discern the cases that
were not considered serious, but resulted in an adverse outcome; this may help ED
determine areas to implement preventive measures in order to avoid any possible
underassessment of patients at risk. Any discrepancy in time of initiation of the treatment
after patient arrival was recorded and delays will be compared and correlated to the final
outcome of the patient. This includes the cases that were managed in a non–health care
facility or at the site of exposure. The percentages of patients initially treated and referred
from another health care facility have also been evaluated.
Treatments, such as the use of antidotes, were recorded to assess the availability
of necessary treatment as well as any deviation from the recommended standards. The
management provided was then classified in the following categories: Decontamination
only, Observation only, No therapy provided, Decontamination and other therapy,
“other” therapy only (without decontamination). Patients’ health coverage,
unemployment, and history of mental illness such as depression, psychotic disorders, or
personality disorders were analyzed. Significance of mental illness in the group of
patients who repeatedly attempted drug or chemical intentional self poisoning has been
explored and the correlation of addiction history with mental illness co-morbidity has
been examined.
Voluntary vs. unintentional, domestic chemical use vs. agricultural and industrial,
occupational vs. environmental, pharmaceutical intentional vs. pharmaceutical adverse
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reaction illicit drug use, and recreational intoxication have been stratified by age, sex,
socio- economic status, employment, presence of history of chronic illness, alcohol use
and mental illness have been examined for correlation with the final outcome of the
poisoning cases.
Although morbidity and mortality of acute poisoning are increased in elderly
compared to younger patients, little has been published on this issue. To investigate the
influence of age on the clinical course of acute poisoning, the cause of acute poisoning
and the clinical outcome have been recorded. As compared with younger patients, mean
length of stay at the ICU, if found to be significantly higher this might indicate a more
serious course of acute poisoning.
3.0. DEFINITION OF VARIABLES
Poisoning was defined as a condition or physical state produced by the ingestion,
injection or inhalation of, or exposure to a deleterious agent. Poison exposure may
include any medicinal drug, environmental, agricultural, industrial, or occupational
substance that may or may not result in a visit to the Emergency Department (ED).
Environmental poisoning is any passive, non-occupational exposure that results from
contamination of air, water, or soil.
Occupational exposure is an exposure that occurs as a direct result of the workplace.
Therapeutic error is an unintentional deviation from a proper therapeutic regimen that
results in the wrong dose, incorrect route of administration, administration to the wrong
person, or administration of the wrong substance.
Drug interactions resulting from unintentional administration of drugs or foods which are
known to interact are also included.
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Unintentional misuse differs from intentional misuse in that the exposure was unplanned
or not foreseen by the patient.
Bite/sting includes all animal bites with or without stings.
Food poisoning is a suspected or confirmed ingestion of food contaminated with
microorganisms.
Suicidal poisoning is a poisoning that results from an inappropriate use of a substance for
reasons that are suspected to be self-destructive.
Intentional misuse is defined as an exposure resulting from the intentional improper or
incorrect use of a substance for reasons other than the pursuit of a psychotropic or
euphoric effect.
Unintentional poisoning is all unintentional exposures not otherwise defined.
Intentional abuse is defined as an exposure resulting from the intentional improper or
incorrect use of a substance where the victim was likely attempting to achieve a euphoric
or psychotropic effect. All recreational use of substances for any effect is included.
The category malicious poisoning is used to capture patients who are victims of another
person’s intent to harm them.
Minor effect is a situation where the patient developed some signs or symptoms as a
result of the exposure, but they were minimally bothersome and resolved rapidly with no
residual disability or disfigurement.
Moderate effect occur when patient exhibits signs or symptoms as a result of the exposure
that were more pronounced, more prolonged, or more systemic in nature than minor
symptoms. Some form of treatment is indicated but Symptoms were not life threatening,
and the patient had no residual disability or disfigurement
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Major effect is defined as when patient exhibits signs or symptoms as a result of the
exposure that was life-threatening or resulted in a hospitalization or in ICU with or
without significant residual disability or disfigurement
Death occurs when patient dies as a result of the exposure or as a direct complication of
the exposure.
4.0. DATA ANALYSIS
Data collected was reviewed and checked for completeness before being entered
into a database and missing values were excluded using a pairwise deletion. The data was
then analyzed using SPSS 16.0 statistical package. Continuous variables such as age,
duration of hospital stay, and duration of time between poisoning and hospital arrival was
analyzed using student’s t test or one-way analysis of variance (ANOVA) between
groups. The categorical data between groups was analyzed by using the Chi square test;
Odds Ratio, and confidence interval, (CI) was calculated by a full factorial univariate
analyses and stepwise multiple logistic regression analysis. Correlation analysis was
conducted using the Pearson r correlation coefficient. Results obtained will be presented
as mean ± SD and percent (%). A p value of less than 0.05 will be considered significant
for the various association between variables specifically association between asthma and
exposure, between exposure and outcome, final disposition, suicidal poisoning and
chronic diseases such as depression psychosis
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RESULTS

Between December 2004 and May 2007 a total of 649 patients’ encounters were
identified. The poisoning diagnosis was made based on a documented acknowledgement
by the patient for taking the drug or by a positive urine drug screen that is done
systematically for any suspected specific exposure. The first section will present the
demographics of the exposure, the second section will explore poisoning agents of
exposure, the third will describe co-morbidities, the fourth section will describe the
correlations between variables, and the fifth section will describe predictors.
1.0. DEMOGRAPHIC CHARACTERIZATION
1.1-

Age and Gender

The distribution of age and gender is shown in Table 1 and Figure 1; age varied
between 1 and 89 years with a median of 39.7 years and a standard deviation of 13.6.

FIGURE 1: Age distribution: cases were predominantly adult between 36 and 45 years
old. Pediatric cases younger than 15 years old represented only 4.6%.
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In the pediatric population 4.6 % were younger than 15 years old and, as shown in
Figure 1, the most frequently affected age was 48 years old and the most commonly
affected age group was between 36 and 45 years old. The middle aged adult population
for both sexes represented 35.7% of the total cases. The younger adult group of 16 to 35
years old represented only 10.6% and ranked third after the 46-55 years old that scored
22.7%. Of the total of 649 poisoning cases there were more male, than female, with
42.7% (n=277) females and 55.9% (n=363) male to female ratio of 1.3.

FIGURE 2: Poisoning distribution by gender: more male, than females were seen with
male to female ratio of 1.3.
Below (Figure 3) is a side-to-side (or a mirror effect) graph of the male to female
frequency on an age range. This population pyramid allows a better comparison of the
various gender differences by age brackets. The distributions of gender by age seem
globally similar, but clearly the peaks look different where females are more common at
ages 40 to 43 as compared to males that peak at 46 to 49 years old. Among children it
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seems there were more poisoning cases among male infants at very early age (2-3 years)
than females.

FIGURE 3: Population Pyramid: distribution of poisoning cases by gender and by age.
Poisoning population peaks at 49 years old in male s and at 40 to 43 in females.
1.2-

Race and Marital Status
The difference in ethnic background was substantial as the poisoning cases were

predominantly African Americans (79.9%).

FIGURE 4: Poisoning distribution by race and age: The poisoning population race is
predominantly African American then Hispanics and Whites in third position. (Race_AA: African
American, Race_Hisp: Hispanic)
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Hispanics were the second most prevalent with 11.9%, followed by Whites at
6.6%. Over 69.3% (n=450) of the total cases were single in comparison to only 12.3%
(n=80) were married. Results of the married and unmarried patients by age are displayed
in Figure 5.

FIGURE 5: Marital Status. Distribution of married versus unmarried patients shows a
predominantly single population as compared to only less than 20% married (Marit_Single:
Marital status single; Marit_Marr: Married)

There were more singles cases than married cases and singles cases were
predominantly aged between 37 and 49 years old.
1.3-

Employment and Insurance Coverage
Most patients were self-covered 45.8% (n=297), 35.1% (n=228) of the cases

were covered by the Illinois Department of Public Aid (IDPA). Only 5.9% (n=38)
patients had private coverage. Medicare and Medicaid covered only 8.2% of the total
cases.
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FIGURE 6: Poisoning by employment status. Most poisoning cases were unemployed
and not covered by any insurance, shown in Figure 6 and Figure 7.
Most patient with poisoning episodes brought to the hospital were unemployed
87.4% (n= 567) as opposed to only 9.4% (n=62) of employed.

FIGURE 7: Population pyramid, Employment distribution by age. The age group that is the
mostly affected was between 37 and 52 years old.
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1.4-

Mode of Arrival

Fifty three percent (n=345) of patients with poisoning were brought by the
Chicago fire department in response to a 911 call from a patient’s families, or from the
police department. Twenty nine point six percent of patients (n=192) walked in the
emergency department or were brought by a family member or in a wheelchair. Only
0.5% of the case visited their primary care physician (PCP) before presenting to the
emergency department.

FIGURE 8: Mode of arrival of patients with poisoning to ED. Chicago Fire Department
brought more than half of the total cases.

The Pearson correlation test showed that there was a significant correlation
between mode of arrival and age (r=-.119, DF=589, p=.004), marital status (r=.113,
p=.006 and DF=627), pulse (r=-.111, DF=622, p=.007), exposure (r==.134, DF=591,
p=.001) and also with the final disposition (r=.111, DF=582, p=.007). Though these
correlations are not strong, it could reflect that the predominance of heroin and cocaine
cases mostly brought by police and fire department resulted in more hospitalizations
compared to the other patients that just walked in or were brought by other means. Also,
these correlations could be related to the fact that the outcome is generally worse when
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EMS brings patients given that EMS is generally called only for situations that seemed
severe or had potential for complications.
Arrival mode was also significantly correlated with the final disposition
particularly to hospital admission (p=0.04). No correlation was established between death
and the way the patient arrived to ED.
1.5-

Chief Complaint Analysis

Given the wide variation of the diverse symptoms related to poisoning, the chief
complaint was classified in seven categories that were estimated to be the most common.
Category one includes unresponsiveness, Loss of consciousness and or Coma and it
included 22% (n=143) of the total patients.
Category two includes cardio vascular complaints such as chest pain, angina, and
or coronary artery disease. This category was the most representive in our series and
more than 25.9% (n=168) of the cases presented with these chief complaints.
Category three is pulmonary related complaints such as Shortness of breath (SOB),
cough, wheezing or exacerbation of a preexisting asthma. In our series, 22.2% (n= 144)
of patients presented with this latter complaint. Category four is drug overdose related
symptoms, this category involved 15.4 % (n= 100) of our patients.
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FIGURE 9: Chief complaint at the level of ED triage. Most patients presented for chest
pain or were brought by CFD unresponsive or with shortness of breath.

1.6-

Vitals on Admission
1.6.1- Temperature on Admission

FIGURE 10: Admission temperature ranged between 86.0 and 105.0 with a median of
98.0 degree Frenheight.
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1.6.2- Heart Rates
As shown below in Figure 12, only 2.6% presented with a bradycardia less than
50 and 56.4% (n=366) presented with pulse between 50 and 100 and 39.4% (n=249) with
pulse over 100.

FIGURE 11: Pulse at arrival to ED. over 35 % of patient had a tachycardia that was
higher than 100beat per min.
1.6.3- Respiratory Rate

FIGURE 12: Respiratory rate on admission. RR was normally distributed that peaks in
the high 20s
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1.6.4- Blood Pressure Systolic

FIGURE 13: Frequency and percent systolic blood pressure on arrival to ED. Over 30%
of patients presented with systolic high BP over 140 and 10% presented with a systolic
BP over 200mm/hg.
1.6.5- Blood Pressure Diastolic
Diastolic blood pressure was not significantly correlated with either heroin or
cocaine use, but it was correlated to alcohol use (p= 0.015) analgesics (p= 0.24) and to
marijuana use (p=. 006).

FIGURE 14: Frequency and Percent of diastolic Blood Pressure on arrival to ED
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1.6.6- Glasgow Scores
Glasgow coma scale, known as Glasgow score; a reliable tool for assessing
consciousness was significantly correlated to heroin (p=0.002) and to cocaine overdose
(p=0.002)
2.0. POISONING AGENTS
Poisoning exposure was grouped into fifteen toxic substances or drugs and in four
different categories: pharmaceutical or medicinal drugs, recreational drugs, chemicals or
chemical industrial. Circumstances of the exposure were also captured and categorized
into seven intent groups that included: suicidal, abuse, intentional, misuse, unintentional
and therapeutic and adverse drug events (ADE); the route of exposure was recorded as:
inhalation, ingestion, and injection, dermatological, vaginal and or rectal.

FIGURE 15: ED poison exposure. The poisoning exposure most commonly encountered
was heroin followed by cocaine and anti- depressant and antipsychotic medications.
Multiple drugs intakes were the fourth most commonly seen poisoning exposure in this
study population.
32

The fifteen exposure substances identified and most commonly encountered in
ED included heroin, cocaine, alcohol, heroin concomitantly with cocaine, multiple drugs,
ASA (aspirin), anti-depressors and antipsychotics, stimulants, analgesics, methadone,
marijuana, multiple drugs, unknown pills, cardio vascular drugs, anti-cold drugs and
others.
In summary agents of poisonings encountered was as follow: heroin represented
35.4% (n=230), cocaine 31.7% (n=206), heroin and cocaine concomitantly taken 4.3%
(n=28), alcohol 2.2% (n=14), multiple drugs 5.5% (n=36), anti depressant antipsychotic
6% (n=39), ASA 3.4% (n=22), cardio vascular drugs 2% (n=13), anti-cold medications
1.1% (n=2.2), methadone .6% (n=4), CNS stimulants .8% (n=5), Analgesics 1.5%
(n=10), Marijuana .5% (n=3), unknown pills 1.7 (n=11), other substances 2.9% (n=19).
The route of the poisoning exposure included inhalation 61.5% (n=400), ingestion in
21.1% (n=137), rectal vaginal 10.6(n=69) and injection at 5.2% (n=34.).

FIGURE 16: Overall route of poisoning exposure. Inhalation as route of exposure was
the most commonly seen route particularly for cocaine and heroin.
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The exposure circumstances included: abuse 76% (n=498), suicidal 13.4%
(n=87), misuse 2.2% (n=14), unintentional 3.2% (n=21), therapeutic 2.5% (n=16) and
ADE .6% (n=4).
2.1- Poisoning and Medical History
There was a significant relationship between asthma and the exposure to heroin
(F=20.4, DF=1, p=0.0001) as well as between history of cardio vascular disease and
exposure to cocaine (F=35.34, DF=1, p=0.0001). Another significant relationship was
revealed between the use of cocaine and history of preexisting hypertension (F=33.34,
DF=1, p=0.0001). Depression and Psychosis were significantly associated with the
overall poisoning exposure variable with (F=42.59, DF=1, p= .0001) and (F=6.96, DF=1,
p=.0001) respectively.
2.2- Relationship of Poisoning to Smoking and Alcoholism
A set of significant relationships were established between poisoning exposure
and the history of smoking (F=2.90, DF=14, p=0.0001). Another significant relationship
(F=3.76, DF=14, p=0.0001) was established between the history of alcohol drinking and
the exposure to poison. History of recreational drug use was also found significantly
related (F=33.64, DF=14, p=0.0001) to the overall exposure variable.
3.0. POISONING CO-MORBIDITY
3.1. Personal Medical History of Diabetes mellitus
There were over 93 diabetic cases that visited the emergency department for
poisoning during the study period and they represented 14.3 %. Twelve cases were
accounted unknown as the history of prior diagnosis was not clear from the patients’
records.
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FIGURE 17: Personal medical history of diabetes and hypertension by age. The
distribution of the cases of diabetes looks uniformly distributed and it reflected the
distribution of the poisoning exposure within the total population (on the Y access Sum
refers to frequency).

The diabetic patients’ ages ranged between 1 and 89 years with a mean of 46.5
and a standard deviation of 11.96, similar to the overall age distribution of the population
studied. More than 59.1% (n=55) were male, 44.1% (n=41) used exclusively cocaine and
29% (n=27) used exclusively heroin, 2.2% used a combination of both heroin and
cocaine, and 6.5% (n=6) combined multiple drugs.
Among poisoned diabetics patients there were 59.1% (n=55) who also had an
associated hypertension and 35.5% (n=33) with cardio vascular diseases and 48.4%
(n=45) of asthmatics. Depression was prevalent among diabetics with 21.5% (n=20), no
correlation with the overall poisoning exposure variable was established.
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3.2- Personal Medical History of Hypertension
Over 31% (n=199) cases were diagnosed with prior history of hypertension.
Among these there were 27.1% (n=54) who used heroin and 47.2% (n=94), who used
cocaine, 4% (n=8) who combined both heroin and cocaine, and 5.5% (n=11) who used
anti-depressants/ anti-psychotics. Smoking was prevalent at 72.4% (n=144) of the
hypertension group, 60.3 %( n=199) were alcoholics and over 85.4% (n=170) had history
of drug abuse. Sixty point eight percent (n=121) reported had taken other prescription
medications the day of their poisoning. Over 71.9% (n=143) of the hypertension patient
were hospitalized as opposed to only 26% who were discharged form ED; .5% (n=1)
died, 58.3% had major effect, and 38.7% were categorized in minor events.

FIGURE 18: Prevalence of chronic hypertension compared to cardio-vascular comorbidity with poisoning. Hypertension (HTN2) and cardio vascular disease (CVD2)
were similarly distributed in all age groups.
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Hypertension was not correlated to the overall poisoning exposure, however it
was correlated to cocaine exposure (p= .0001). No age difference was seen that could
explain this significance level.
3.3.

Personal Medical History of Cardio-vascular Diseases

The number of patient that presented to emergency department with a preexisting
history of cardio vascular diseases (CVD) represented 17.4 % (n=113). Cardiovascular
disease included all heart problems and a Pearson correlation test indicated heart disease
was significantly correlated to cocaine abuse (r=.227, DF=645, p= .0001).
3.4.

Personal Medical History of Arthritis

Personal medical history of arthritis was only seen in 3.5% of the cases (n=23)
and no significant correlation with any other variable was established, including the
exposure to heroin that has been previously indicated to cause a degree of arthritis.
3.5. Personal Medical History of Malignancy
Malignancy was rarely seen among cases of poisoning of our study; only 7
patients presented for poisoning among the 649 cases identified, and no correlation
between history of cancer and drug abuse or suicidal attempts were found. Contrary to
the initial hypothesis, that patients with cancer might be at higher risk for poisoning
because of multiple toxic chemotherapies, as well as their depressive mental state, that
make them more susceptible for attempting suicide.
3.6. Personal Medical History of Asthma
Asthma was of special interest to this study and it was investigated for possible
correlation with multiple other variables, we identified the following findings:
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FIGURE 19: Smoking & regular drinking habits in Asthma, Depression & Psychosis

Over 41.4 % of our study population had a history of confirmed diagnosis of
asthma (n=269). Among the 269 asthmatics, there were 45.4% (n=122) who presented to
ED for a complication related to heroin intake during the last 24 hours before admission.
Cocaine related visits among asthmatics represented 30.5% (n=82), and alcohol
poisoning accounted for 2.6% (n=7) of all asthma cases. Concomitant use of heroin and
cocaine represented 5.2% (n=14), and multiple drugs intoxication was seen in 4.5%
(n=12) of cases. Marijuana seems to be rare as a cause for emergency visit among
asthmatics and our population rate was recorded at only 1.1% (n=3.)
Asthma patients who visited ED for a poisoning event had almost equal
distribution of gender; 50.9% (n=135) were female, 49.1% were male. Over 72% (n=195)
were single as opposed to 11.9% married (n=32). Asthma cases were predominantly
African American 85.9% (n=231) with 3.3% Hispanic (n=9) and 3.7% (n=10) of white
descent. Sixteen percent of our asthmatic population were also diabetics, 31.6% (n=85)
had hypertension, 14.5% (n=39) reported cardio-vascular problems, 3.7% of them had
been diagnosed with an arthritis, and 2.6(n=7) had a past or current malignancy.
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Depression co-morbidity among asthma patient was recorded at 18.2% and 8.6%
(n=23) were diagnosed and treated for a psychotic disorder. Most asthma patients had a
history of recreational drug use 86.1% (n=229), 24 cases (9%) were seen in the
emergency department for a self poisoning. Therapeutic adverse events were also
reported among asthma patients at a rate of 2.2% (n=6) and misuse of drugs at a rate of
1.1% (n=2).
History of prior poisoning and ED visit or hospitalization for similar events was
prevalent. In fact over 54.3% (n=146) of asthmatics were documented with prior
incidents of poisoning that needed a trip to ED at least once. Inhalation was the most
commonly reported mode of exposure of asthmatics 75.5% (n=203), ingestion was seen
in 11.5% (n=31), then injection 6.3% (n=17), rectal or vaginal at 4.5% (n=12), and
dermatological 1.1% (n=3.) Smoking was prevalent among asthmatics at 65.1% (n=175)
and regular alcohol intake was associated with asthma in 54.6% (n=147). Only 25%
(n=68) of asthma patients had received initial management on the site of the poisoning
exposure or immediately at arrival to the emergency department and 11.5% (n=31) were
given immediate antidote administration.
From the total 269 patients only 14.5% (n=39) were discharged and 71.7%
(n=193) were admitted to the hospital or to the ICU for further management. According
to the ER physician, the assessment of the outcome reported that the poisoning events
were major in 55.8% where the patient needed extra measures in order to treat their
poisoning exposures, necessitating sometimes ICU hospitalization, intubation or
admission to the hospital.
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The records showed that 84% had had a follow up at the outpatient clinic or were
referred to their primary care physician. At the time of the exposure, 67.7% of asthma
patients reported that they were taking their asthma routine maintenance medication and
53.2% of the total asthma groups were under albuterol treatment.
A significant relationship between the exposure to heroin and history of Asthma
was established (p=0.0001). Asthma was not correlated to any of the other substances of
exposure including cocaine, alcohol, or concomitant use of heroin and cocaine. ANOVA
test resulted in a statistically significant relationship between asthma and depression (p=
.044) and to psychosis (.028), however smoking was not significantly associated with
asthma (p= .066).
TABLE-1: Summary Table for Diabetes, Asthma and hypertension; demographics
and agents responsible for poisonings.
Diabetes

HTN

Asthma

Total study
population(N)

14.3% (n=93)

31% (n=199)

41.4% (n=269)

Age

45.9 +/- SD 11.8

47.6 +/- SD 11.3

39.2 +/- 11.9

Gender

M=60.4%, F=39.6%

M=66.3%, F= 33.7%

M=49.1%, F= 50.9

Heroin

29% (n=27)

27.1% (n=54)

45.4 % (n=122)

Cocaine

44.1% (n=41)

47.2 % (n=94)

30.5% (n=82)

Smoking

67.7% (n=63)

72.4% (n=144)

65.1 % (n=175)

Alcohol

53.8% (n=50)

60.3% (n=121)

54.6% (n=147)

Depression

21.5% (n=20)

17.6 % (n=35)

18.2% (n=49)

Psychosis

11.8% (n=11)

11.6 % (n=23)

8.6% (n=23)

Hospitalization
rates

73.1% (n=68)

71.9 % (n=143)

71.7% (n=193)
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3.7.

Personal Medical History of Depression

In our series Depression accounted for 21.6% (n=140) of the total cases and a
significant relationship was found between poisoning and history of depression. Many
patients that attempted suicide ingested a higher dose of their own medications for the
purpose of self-harm. A smaller number presented for adverse drug reaction of antidepressor mainly Tricyclics. Over the 141 cases 27.1% (n=38) visited ED for cocaine
related poisoning event and 17.1% (n=24) presented for heroin poisoning. The third most
common poisoning seen in depressed patients presenting to ED was anti-depressants
15.7% (n=22), multiple drugs 11.4% (n=16), salicylic acid (ASA) 9.3% (n=13), and
unknown pills .7% (n=1).
In patients with depressive mood disorders, gender distribution was slightly in
favor of females with 53.6% (n=75) versus 46.4% (n=65) males with a male female ratio
of .8 mostly single 70.7% (n=99) versus only 11.4% of married. African American was
the major race in this group with 72.9% (n=102); Hispanics were 7.1% (n=10) and 8.6%
(N=12) were Whites. The majority in the depression group were unemployed at 85.8%
(n=121), 47.1% covered with IDPA, and 35% were self-payers.
Over 48.6% (n=68) of the depression group were brought by the EMS and 25.7%
(n=36) arrived to ED unresponsive and 25% (n=35) of them had a heart related
complaint, 12.9% (n=18) had a chief complaint that was classified as overdose (OD).
Suicidal intent was recorded in 42.9% (n=60), and another major circumstance of
poisoning in the depression group was drug abuse at 52.1% (n=73). Unintentional and
misuse was only seen in less than .7% (n=1). Medication was the most commonly used in
this group at 45% (n=63). The main route of poisoning in this study group of documented
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depression patients was the ingestion route 47.1% (n=66) and the inhalation route 45.7%
(n=64). Rectal or injection routes were equally recorded at 2.9% (n=4) each.
Co-morbidity of depression was recorded as follow: Asthma 34% (n=48),
diabetes 14.3% (n=20) hypertension 25% (n=35) Psychosis 33.6% (n=47) cardio vascular
diseases 17.9% (n=25) and arthritis 3.5% (n=5). Of the 141 patient 15% (N=21) that
received immediate management at the site of the poisoning, and 8.5% received
Naloxone antidote on arrival to the emergency room. Beside antidote and initial
intervention on the site 20% (n=28) received decontamination only, 35% (N=49)
received decontamination combined to other appropriate therapy and 36.4% (n=51)
received other therapy without decontamination.
Fifty-four percent of the depression group acknowledged smoking tobacco, 55%
(n=76), regular alcohol intake, 66.7% (n=94) admitted the use of recreational drugs. Over
half of the intoxication resulted in minor effects, 47.5% had some complication and
resulted in a major outcome (but not death), and 75.7% (n=106) were admitted to the
hospital for further evaluation and management. The average length of stay was at 1.4
days. Of the regular prescription medication noted taken for asthma maintenance
treatment, albuterol was reported by 14.2% (n=20), anti-depressant medication in 8.5 %
of patients, anti-hypertensive medication 8.55 (n=12), and clonidine in 1.45 (n=2).
Of the total cases 11.9% (n=77) were diagnosed and documented with a psychotic
disorder. Their age varied between 20 and 66 years old, with a mean of 39.32 and a
standard deviation of 9.55. Patients in this group were predominantly single (79.2%, n=
61) African American (83.1%, n=64), male (58.4%, n=45) with a male to female ratio of
1.4.
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Hispanics represented 3.9% (n=3) of cases and whites represented 9.1% (n=7); only 6.5
% (n=5) were employed. Insurance coverage was provided by IDPA 51.9% (n=40),
Medicare 7.8% (n=6), and 27.3% (n=21) were self-payers.

FIGURE 20: Depression and of Psychosis (PSYCH2) by age. The age group the most
involved is the middle aged between 36 and 45 years old, the same age group affected by
asthma and diabetes and hypertension.

3.8.

Personal Medical History of Psychosis

Chicago fire department EMS brought over 56% (n=39) of them to ED and 31.2%
(n=24) were walk-ins. Over 24.7% (n=19) had a heart related complaint, 13% (n=10) had
chest complaint like shortness of breath, 5.2% presented for nausea and/or vomiting.
Overdose as the chief complaint was seen in 13% (n=10) and none of the psychotic
patients presented for injury following an event of poisoning.
Among the group of psychotics there were 14.3% of diabetics (n=11), 29.9%
(n=23) hypertensive, 18.2 %( n=14) with cardio vascular diseases, 29.9% (n=23)
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asthmatics, 62.3% (n=48) with a diagnosed depression disorder, and (1.3%) with a
malignancy. Of the total patients with known psychotic disorders 42.9% (n=33) had
previously visited ED or were hospitalized for a poisoning related event.
Over 19.5% (n=15) of the patients with history of psychotic disorders had heroin
poisoning, 33.8% (n=26) had cocaine poisoning,18.2% (n=18) were poisoned with their
own prescription medication, and 7.8% (n=6) to multiple drugs combination. Alcohol
resulted in intoxication in this group only in one case (1.3%).
In summary, the above poisoning exposures were distributed in 5 categories:
58.4% (n=45) illicit drug overdoses, 33.8% (n=26) pharmaceutical poisoning (though
some drugs were also taken for recreational purposes), 7.8% (n=6) chemical industrial
poisoning. Circumstances of the poisoning were collected from the History and physical
(H&P) report and were as follow: suicidal 28.6% (n=22), recreational 64.9% (n=50)
unintentional accidental 2.6% (n=2), and therapeutic error 2.6% (n=2). Concomitant
medication intake was reported for antidepressant/antipsychotic for 13% (n=10), for
albuterol in 11.7% of the cases, for anti hypertension medications 9.1% (n=7) of cases
and clonidine in 2.6% (n=2) of the cases.
The route of exposure was recorded as follow: inhalation 53.2% (n=41), ingestion
35.1% (n=27), rectal or vaginal 10.4% (n=8), and injection for 1.35% (n=1). Over 15.6%
(n=12) received initial management on site, and 11.7% were given Narcan by the EMS
technicians or immediately at arrival to ED. Decontamination only was ordered in 16.9%
(n=13), observation only was done in 7.8% (n=6), 27.3% received decontamination with
some other therapeutic measures, and 42.9 % received other therapy without
decontamination.
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Over 76% (n=59) of the psychotic patients that presented to ED for a poisoning
related complaint reported smoking tobacco, and 61% (n=47) reported taking alcohol
regularly. As many as 77.9% (n=60) of this group with documented psychotic disorders
acknowledged to their ER physicians that they took illicit drugs. Among the total 77
patients in this group only 11.7% (n=9) of patients were discharged home, the rest
(77.9%, n=60) were hospitalized. The final outcome was subjectively assessed as major
in 49.4% (n=38), as a minor effect in 46.8% (n=36); no deaths occurred in this group.
The average length of stay was 1.3 days and follow up after discharge was done in 87%,
through outpatient clinics and primary care physicians.
3.9.

Personal Medical History of other Mental Illnesses

In the process of data collection, it was deemed logical to collect information on
other mental illnesses that might be associated with depression and psychotic disorders
that may influence the patient’s risk for self poisoning. However, the data was limited
and only 3.5 % (n=19) had other concomitant psychiatric disorders such as generalized
anxiety disorders, seen in 1.3% of the cases.
3.10.

History of Smoking

Since the review of literature has shown only rare cases of isolated tobacco
intoxication where tobacco was the primary poison that necessitated emergency visit,
smoking exposure was not initially considered the list of poisons of interest. However, an
assessment of smoking status was included in order to assess its prevalence among ED
related poisoning cases. Over 60.9 % (n=395) were tobacco smokers; smoking was self
reported on admission and documented on the patient chart systematically as part of the
initial H&P assessment.
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FIGURE 21: Smoking and alcohol (ETOH2) co-morbidity by age.

Smokers were aged between 17 and 72 years with a mean of 41.37 and a SD
10.44. Over 41.7% were female and 58.3% male with a sex ratio of 1.4. Of the total 395,
13.2% (n=52) were married and 71.9% (n=284) were single. Eighty two percent (n=324)
of the smoking patients were African American, 5.1% (n=21) Hispanic, and 5.3% (n=21)
White. Smokers’ rate of unemployment was 88.4% within our population. Over 34.7%
(n=137) were covered by public aid, 5.8% (n=23) by Medicare, 1.5% (n=6) by Medicaid
and the rest did not have any insurance coverage 46.1% (n=182). Patients arrived to the
ED primarily by walking 29.9% (n=118) or by the Chicago Fire Department 54.2%
(n=214). Their chief complaints were chest pain and heart related complaints (33.4%,
n=132), shortness of breath (25.1%, n=99), unresponsiveness, confusion to coma (18.7%,
n=74), drug overdose (11.1, n=44), vomiting (2.8%, n=11), and suicidal
acknowledgement at arrival to ED for (1.3%, n=5).
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Among the smokers’ group 15.9% (n=63) were diabetics, 36.5 % (n=144) had a
history of chronic hypertension, 19.7% (n=78) had a history of cardio-vascular diseases,
3% (n=12) had chronic arthritis and there were .8% (n=3) cases of diagnosed cancer.
History of depression among smokers visiting ED for poisonings was noted in 19.2%
(n=76) and history of psychosis was recorded in 14.9% (n=59). The proportion of regular
alcohol drinkers among smokers was 73.4% (n=290) and a history of prior similar
poisoning events that necessitated emergency visit was 47.6%. Among the same group,
77.5% (n=306) presented to ED for illicit drug related poisoning, as opposed to only
12.7% (n=50) for pharmaceutical drug poisoning and 9.1% (n=36) for industrial chemical
poisoning. Tobacco smokers were poisoned with cocaine in 39.2% (n=155), heroin in
35.9% (n=142), heroin cocaine combination in 4.8% (n=19), multiple drugs in 5.1%
(n=20) salicylates in 2% (n= 8) and analgesics in 1% (n=4). Methadone, stimulants, and
marijuana all together accounted for 1.3% (n=5).
The route of the poisoning exposure in smokers was mainly inhalation in 70.6%
(n=179) followed by ingestion in 12.4% (n=49), rectal and vaginal in 9.9% (n=39), and
injection in 5.8% (n=23). Poison exposure in smoking patients was categorized as
follows: drug and medicinal abuse for 85.1% (n=336), suicidal for 9.6% (n=38), misuse
and unintentional for 1.8% (n=7) and therapeutic and adverse drug reaction for 2.5%
(n=10). Over 19.5% (n=77) of cases received initial management intervention at the site
of the exposure and another 13.4% (n=53) patients received injection of Narcan antidote.
ED management among smokers consisted of decontamination only 15.4% (n=61),
observation only 6.1% (n=24), decontamination and other therapy in 28.6% (n=113).

47

Among this group of smoking patients, there were 46% who were managed by using
other means that does not include decontamination.
History of drug abuse in poisoning related ED visits in tobacco smokers was
reported to be 91.4% (n=361). As many as 65.3% (n=258) were admitted to ICU or to a
department other than ED and only 20.8% (n=82) were discharged; no death was reported
among poisoned smokers. After discharge from the hospital 82.8% of poisoned smokers
were given an appointment for follow up in outpatient clinics or with their primary
physician. Concomitant consumption of other prescription medication taken for any other
reason but poisoning the day of the poisoning was as follow: Albuterol 24.3% (n=96),
anti-hypertensive 7.8% (n=31), anti depressant or anti psychotic 5.1% (n=20), clonidine
in 1.5% (n=6) and analgesics 1% (n=4). The average length of stay among the smokers
group was .9 day.
3.11.

History of Alcohol Intake

This study also had an interest in assessing the prevalence of alcohol consumption
and its effect on possible intoxication events, considering alcohol alone, or its
involvement in potentiating other substances.
Over 53.5% (n=347) reported alcohol intake routinely but the information
available failed to provide a consistent assessment of the quantity taken and how often.
Seventy four cases had unknown alcohol use and information was not available on the
chart. Only 4 cases were missing altogether. The age ranged between 15 and 66 years,
41.5% (n=144) female and 57.1% (n=198) male with a male to female ratio of 1.3. Sixty
nine point five percent (n=241) were single and 15% (n=52) married. Over 81% (n=282)
were African American, 5.8% (n=20) were Hispanics and 5.8% (n=20) were whites.
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Most of the poisoned alcoholic group (87%, n=302) were unemployed. Only 34.9% were
covered with IDPA, 44.7% (n=155) were self-payers, 6.3% (n=22) covered by Medicare,
and 2% (n=7) by Medicaid. Chicago fire department (CFD) brought 51.9% (n=180), and
28.8% (n=100) of alcoholic poison related patients visiting ED were walk in. twenty one
percent (n=73) were confused or unresponsive, 31.1% (n=108) had a chief complaint that
was heart related 21.6% (n=75) had shortness of breath and 13.8 complained expressed
an overdose related event at arrival to ED triage system. Vomiting was a chief complaint
in 2.9% (n=10), suicidal attempts was found in 2.6% (n=9) of cases, and one case of
injury related poisoning. Diabetes mellitus was present in 14.4% (n=50), Chronic
Hypertension in 34.6% (n=120), cardio vascular diseases in 20.2% (n=70), arthritis in 4%
(n=14), asthma in 42.4% (n=147) and cancer in 1.7% (6 cases).
Depression was present among alcohol users (22.2%, n=77) and diagnosed
psychosis was present in 13.5% (n=47). The rate of smoking among alcoholics was
83.6% (n=290), history of poisoning events that necessitated ED consultation was at
48.1% (n=167) and history of illicit drug use was very high among them (92.2%, n=320).
Among alcohol users, cocaine was the highest poisoning exposure (39%, n=135),
then heroin (33.4%, n=116); heroin. Cocaine combination was seen in 4% (n=14) of
cases. Though the rate of abuse is very high in this group, it seems that alcohol using
patients are cautious with their intake in that the rate of alcohol related ED visits was very
low (2.9%, n=10). It is important to note that alcohol intoxication might have been coded
in a separate category other than poisoning, such as in an abuse category that is not part
of this study. Multiple drugs were taken in 7.8% (n=27) of cases, aspirin intoxication in
2% (n=7), anti depressors and antipsychotics in 6.1% (n=21), and unknown pills,
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marijuana, analgesics stimulants, and methadone were 2.7% (n=9) of cases. The major
route of exposure reported was inhalation with 66.9 (n=232), then ingestion in 16.1%
(n=56), and rectal and or vaginal at 10.4% (n=36); in this group drug injection was seen
in only 5.5% (n=19).
The circumstances of poisoning was not much different from the smoking group
as abuse represented 83.6% (n=290), misuse and un-intentional 2.1% (n=7), and
therapeutic and adverse drug reaction were at 1.5% (n=5). Suicidal circumstance was
high in poisoned cases with habit of regular consumption of alcohol at 11.6% (n=41) but
not as high as suicidal poisoning among smokers. Twenty one point three percent (n= 74)
were discharged, and 65.7% (n=228) were admitted to the hospital. Of the hospitalized
patients, follow up was offered to 80.4 % (n=279). Patient reported that other prescription
medications were taken within last 24 hours before the poisoning event as follow:
albuterol in 21% (n=730), antidepressant anti psychotic 6.1% (n=21), and anti
hypertensive in 7.5% (n=26).
3.12.

History of Recreational Drug Use

FIGURE 22: Prior History of illicit drug abuse by co-morbidity. Approximately 80% of
the patients have had a history of prior use of illicit drug use.
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Overall, 80% of the cases that presented to the ED reported past history or current
use of illicit drugs for recreational use. Among those 80% who voluntarily
acknowledged the use of recreational drugs, 39.4% (n=256) were single heroin users 35.5
% (n=231) were single cocaine users. Marijuana was only reported in 1.7% of the cases,
this very low rate of marijuana related events could be explained by the low toxicity of
marijuana that results in very rare cases of ED poisoning related visits, however similar
to alcohol, some of the marijuana events could have been coded under a different code
such as abuse instead of poisoning. Twenty nine percent (n=190) of patients who reported
the use of at least 2 drugs concomitantly, such as: cocaine concomitantly with something
else 14% (n=91), heroin with something else 5.1% (n=33) alcohol with something else
5.7% (n=37) and 2.6% (n=17) who smoked marijuana while using another type of drug.
4.0. ANALYSIS OF ER MANAGEMENT & FINAL OUTCOME
ED management included decontamination in only 16.9% (n=110) of cases, while
combined decontamination with other therapeutic measure was seen in 28.5 % (n=185) of
cases. Seven point four percent (n=46) benefited from observation without any other
intervention. Therapeutic measures were given to 43.1%. Only 2 cases were documented
as refusing treatment offered (.3%). There were 25 cases (3.8%) where information
treatment was missing.
4.1- Initial Site Management Effect on the Final Outcome
Of the total patients, over 34.7% (n=128) needed an urgent intervention at the site
of the exposure and it was documented in the patients chart or in the Chicago Fire
department transfer sheet attached to patients’ charts. No specific details about the
intervention were collected, as it varied from simple perfusion to mechanical ventilation,
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but the need for Naloxone administration on site or upon the patient’s immediate arrival
to ED was captured. Fourteen point five percent (n=92) were found unconscious and
Naloxone (Narcan®) administration was immediately administered at the site of the
exposure or at arrival to ED in order to counteract the effect of the poison.

FIGURE 23: Major Outcome and final disposition by Initial Management at the Site of
the poisoning event. Both the final outcome (OUTC_MAJOR) and the number of patients
that were admitted (DISP_ADMITTED) to the hospital following a poisoning event
depended on whether or not they have received initial management such as Narcan®
injection or other treatment on the site of the poisoning.

4.2. Poisoning Final Outcome
The outcome for each case is assessed and categorized into four categories: No
effect; fair or minor effect; complicated or major effect; and death. Major effect was
issued if the patient had been admitted to ICU, if he was injured; case resulted in
permanent damage, long hospitalization or in a significant complication of his associated
preexisting diseases.
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In our series, there were 49% (n=318) major effects recorded, versus 45.3% minor
effect and 3.8% were classified as no effect of the exposure on the patient. Death was
recorded in .6% (n=4) cases.

FIGURE 24: Rates of admissions by various co morbidities. Admission rates of the six
above groups of patients with co morbidities ranged between 70% and 80%, but history
of cardio vascular diseases was the highest group to be hospitalized.

Of the cases that were classified as major effect, there were 37.9% (n=118)
female and 62.1% (n=194) male cases aged between 14 and 80 years old. Eleven point
nine percent (n=38) were suicidal and 83.3% (n=265) had used an illicit drug for the
purpose of recreation. Fourteen point five percent of them were married and 68.6% were
singles, 80.5 % were African American. Sixteen point four percent of the total 318
patients arrived to ED unresponsive or confused, 36.8% presented with a heart related
complaint and 28.3% were short of breath. There were 16.4% (n=52) were diabetics,
36.5% (n=116) had hypertension, 23% (n=73) had cardiovascular diseases and 47.2%
(n=150) had chronic asthma. In this group the adverse outcome of depression was present
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in 20.8% (n=66), psychosis in 11.9% (n=38). Sixty seven percent (n=213) of tobacco
smokers and 59.4% (n=189) of alcohol users. Heroin exposure resulted in a major
outcome in 29.9% (n=95), cocaine in 44.3% (n=141), multiple drugs intoxication in 5%
(n=16), and anti-depressors in 5.3% (n=17).

4.3- Correlation of Outcome and Emergency Site Management
A significant relationship (F= 6.035, DF=2 and p= .003) was found between the
type of the initial on-site management and the final outcome. Patients who had some kind
of management on the site of the exposure seemed to have recovered better. A significant
relationship was also seen between final disposition, and initial site management
(F=20.37, DF=2, p= .0001).
4.4. Prior History of Poisoning
Over 40% (n=265) of patients reported prior history of poisoning that needed a
visit to ED, and were documented and verified in their charts. Of these 265 cases 17.2 %
(n=112) overdosed with heroin and 18% (n=117) overdosed with cocaine.

FIGURE 25: Documented prior history of poisoning and illicit recreational drug uses by comorbidity.
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One point four percent (n=9) were poisoned with heroin in association with a second
agent, and 3.7% visited the ED for cocaine poisoning concomitantly with something else.
In summary, there were 6.6% (n=43) cases had a history of double agent poisoning and
1.1 % (n=7) had triple agent poisoning.
4.5. Follow-Up
As shown in figure 27, over 80.8% (n=525) of patients were sent for follow up to
the outpatient services or to their primary care physician, of these 525 patients 64.8%
(n=340) were sent to outpatient care and 17.5% (n=92) were sent to their primary care
physician (PCP).

FIGURE 26: Percent of after hospitalization follow-up. Approximately 20% of the total
cases were lost for follow up.

4.6. Final Disposition
Overall, 62.9% (n=409) of patients required further management measures other
than that received in the emergency department, and were transferred to inpatient
services. Seventy eight percent were admitted to the emergency department for
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observation, .6% (n=4) died, and the remaining 22.5% (n=146) were discharged except
for 2.2% (n=14) which were missing and may represent cases that left against medical
advice or eloped from the emergency department.
More males 62.1% (n=90) than females 37.9% (n=55) were discharged from ED,
and the age median was 40 years for this group of patients. This may indicate that more
females were hospitalized because their poisoning event looked more serious or because
they did not respond to the initial management in ED.

Figure 27: Final disposition distribution. Most patients were transferred to
another department in the same hospital, approximately 10% were admitted to ED for
observation and around 20% were discharged.

Among the group of patients that were discharged from ED, 79.5% (n=116) of
them had an event related to the use of a recreational drug, 15.1% (n=22) from the use of
pharmaceutical drugs and 4.8% (n=7) were poisoned with a chemical that was industrybased.
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In the Admitted group, patients’ ages varied between 1 and 85 years, mean 40.69
(+/- SD 13.067), 45.2% were females and 54.8% were males; 70.2% of them were single
and 11.2% married; 65% were exposed to illicit drugs and 23.5% to pharmaceutical
drugs.
Over 47.2% (n=193) were asthmatics, 35% (n=143) had chronic hypertension,
22.7% (n=93) had cardio vascular disease, 4.4% (n=18) had chronic arthritis, and 1.2%
(n=5) had a malignancy. Depression was present in 25.9% of the hospitalized group,
psychosis in 14.7% (n=60), smoking in 63.1% (n=258), and alcohol use in 55.7%
(n=228). Suicidal poisoning were present in 16.1% (n=66) and abuse in 73.8% (n=302);
their average length of stay was 1 day.

FIGURE 28: Admissions and discharge were highest during the first shift then decline
sharply during the third shift (Disp_Disch: disposition discharged; Disp_Admitted: Disposition
Admitted to hospital, disposit. 4= died).
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5.0- ANALYSIS OF CORRELATION
One of the primary interests of this study was to explore the significance of the
relationship between asthma and heroin use in the population of ED that was reported in
the literature, for which many mechanisms were speculated, but none confirmed. In fact
Chicago has one of the highest mortality rates and prevalence of asthma, and also one of
the highest prevalence of drug abuse which makes these two variables of special interest
for this study.
After checking the observations’ independence and verifying the normality of the
population, bivariate analysis with computation of both a Pearson test and a (2-tailed) t
test was performed. It is a measure of correlation that varies between -1 and +1, with 0
indicating no relationship (random pairing of values) and 1 indicating perfect
relationship, i.e. "The more the x, the more the y, and vice versa." A value of -1 is a
perfect negative relationship, i.e. "The more the x, the less the y, and vice versa. R square
is the coefficient of determination, the square of the Pearson correlation coefficient, and it
represents the percent of the variance in the dependent variable explained by the
independent. The significance level of the Pearson test was set at 0.01
After bivariate analysis, a partial correlation test was performed. Both the
bivariate and the partial test have shown a statistically significant relationship between
asthma and heroin use with coefficient at (r= .175, DF=647, p=0.001). This relationship
is positively correlated, indicating that an increase of one variable results significantly in
an increase of the second and may be explained as such: the overuse of heroin may
exacerbate asthma. Or the opposite effect could also be true: when having a history of
asthma this may predispose this group of patients to over-use heroin, knowing that the
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latest research is pointing toward genetic predisposition for both of them (Matthias 2007,
Xuei et al., 2007, Balaci, 2007)
The bivariate correlation (2 tailed) t test showed a strongly significant correlation
between heroin and asthma with (r=.175, p= .0001). An “r” partial Pearson correlation
test, which gives the advantage of correcting for the effect of other confounding factors
by blocking the effect of other variables that may participate in the correlation of interest,
was also performed.
After correcting for the effect of depression, psychosis, smoking, alcohol, ASA
exposure, prior history of poisoning, anti-depressor and anti-psychotic drugs, methadone,
and cocaine exposure, it was found that the significance between asthma and heroin
disappeared, and the Pearson coefficient dropped to .074, the p value increased to 0.061,
becoming statistically non significant. This could be interpreted to mean that there was no
true correlation between variables of interest.
5.1-

Depression Correlations

Depression was significantly correlated with the variable suicidal attempt (r=.275,
DF=647, p=.0001), and with multiple drugs exposure, (which is most likely deliberate
intake for the purpose of suicide or abuse), (r=.136, DF=645, p=.001). Another
significant relationship was found between depression and history of psychosis (r= .352,
DF=647, p= .0001) and between depression and the exposure to antidepressors/antipsychotic drugs (r= .215, DF645, p= .0001), as well as with the use of
ASA (p=.172, DF=645, p=.0001). Heroin exposure was negatively correlated to
depression (r=-.200, DF=645, p= .0001).
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As far as the route of exposure the bivariate analysis has shown that ingestion
route was significantly correlated (r=335, DF=647, p=.0001), inhalation route was also
found significant but it was negatively correlated (r=-175, DF=647, p=.0001).
Disposition was categorized in discharge, admission to the hospital and death. The
analysis revealed that depression and discharge from the hospital were negatively
correlated (r=-.103, DF=647, p= .009). Depression and admission to the hospital were
positively correlated (r= .138, DF=647, p=.0001), which simply translates to an
unfavorable prognosis of poisoning when depression was present. This could also be due
to the higher dose intake of the drug due to the presence of depression or it may be due to
the choice of the drug itself that is different when the patient is depressed and having
suicidal thoughts.
The poisoning agents were categorized as: pharmaceutical drugs/medications,
chemical domestic, chemical industrial, or occupational and recreational exposure. Only
pharmaceutical drugs/medications were significantly correlated to depression (r= .307,
DF=647, p=.0001).
Suicidal poisoning were positively correlated (r= .453, DF=647, p=.0001), abuse
was also significantly correlated to depression (r= -.305, DF=647, p=.0001)
TABLE 2: Summary list of depression significant Correlations.

Variable 1
Depression

Variable 2

R

DF

p Value

ASA

.172

645

.0001

Heroin

-.200

645

.0001

Admission to Hospital
Pharmaceutical drugs

.138
.307

647
647

.0001
.0001

Suicidal poisoning

.453

647

.0001
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5.2-

Psychotic Disorders

Psychosis was significantly correlated to depression as previously mentioned, to
heroin (r= -121, DF=645, p= .002), to smoking (r=.118, DF=647, p= .003), to insurance
coverage (particularly IDP) (r=129, DF=647, p= .001) and self-coverage (r= -.137,
DF=647, p=.0001). Similar to depression psychotic disorders were also found to be
significantly correlated to prescription medication of anti-depressant and anti-psychotics
(r= .190, DF=645, p=0001), which is generally their prescription medication and to
ingestion the route (r=.125, DF=647, p= .001).
Admission disposition is also strongly correlated with psychotic disorders (r=
.113, DF=647, p= .004) as well as to pharmaceutical drugs (r= .114, DF=647, p= .004).
Suicidal circumstance was also significantly correlated with psychotic disorders (r= .163,
DF=647, p= .0001) and to abuse circumstances (r= .102, DF=647, p= .009).
TABLE 3: Psychotic disorders significant correlations with poisoning.

Variable 1

Psychosis Co-morbidity

5.3-

Variable 2

R

DF

p Value

Smoking
Insurance IDP
Anti-Depr/Anti-Psych
Ingestion route
Admission
Prescription drugs
Suicidal poisoning

.118
.129
.190
.125
.113
.114
.163

647
647
645
647
647
647
647

.003
.001
.0001
.001
.004
.004
.0001

Illicit drug abuse

.102

647

.009

Heroin Poisoning Correlations

Heroin was found to be correlated to many other variables in our population, such
as depression, psychosis, cardio vascular diseases (r= -.181, DF=644, p= .0001), to
cocaine (r= -.508, DF=645, p= .0001), to abuse of heroin and cocaine combination (r= 61

.158, DF=645, p= .0001), to multiple drugs exposure (r= -.180, DF=645, p=000), history
of drug abuse (r=286, DF=635, P=000), to the Hispanic race (r=-146, DF=645, p=000),
to self insurance (r=212, DF=644,p=000), to arrival by CFD (r=213, DF=643, p=000),
arrival to ED by walking (r= -.143, DF=645, p=000), chief complaint Unresponsive
(r=152, DF=645, p=000), chief complaint heart related (r=0.268, DF=645, p=000),
shortness of breath chief complaint (r=177, DF=645,p=000), Aspirin intoxication (r= .139, DF=645, p=000), anti depressor/anti-psychotic exposure (r= -139, DF=645, p=000),
ingestion route (r=-359, DF645, p=000), rectal vaginal route (r=.350, DF= 645, p=000),
management at the site of the exposure (r=.111, DF=630, p=000), suicidal poisoning (r= .234, DF=245, p=000), circumstance abuse (r= 324, DF645, p=000) and concomitant
intake of other substances (r=.258, DF=645, p=000).

TABLE 4: Summary of heroin poisoning correlations.
Variable 1

Heroin Poisoning

5.4-

Variable 2

R

DF

p Value

Vaginal or rectal route

.350

645

.0001

History of drug abuse

.286

635

.0001

Heart related CC

.268

645

.0001

History Illicit drug abuse
SOB (CC)
Asthma
Depression
Suicidal poisoning

.324
.117
.174
-.118
-.234

645
645
645
644
645

.0001
.0001
.0001
.0001
.0001

Cocaine Poisoning Correlations

Cocaine was found to be significantly correlated to chronic hypertension (r= .220,
DF=745, p=.0001), and to cardiovascular diseases (r= .227, DF=645, p=0001. Cocaine
was also significantly correlated to heroin, to heroin cocaine combination, (r= -145,
DF=745, p=000), to multiple drugs (r=-.166, DF=645, p=000), to smoking (r=201,
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DF=645, p=000), and to the habit regular alcohol intake (r=.165, Df=645, p=000), to
history of drug abuse(r= .245, DF=645, p=000, ), to age (r= .227, DF=645, p=000), to
race White (r=-.140, DF=645, p=000), arrival mode through CFD (r=-149, DF=645,
p=000), arrival walking (r=173, Df=645, p=000), chief complaint unresponsive (r=-.234,
Df=645, p=000), chief complaint heart related symptoms such as chest pain (r= .507,
Df=645, P=000), chief complaint vomiting (r=-.200, Df=645, p=000), anti depressors and
anti psychotic exposure (r=-.173, Df=645, p=000), ingestion route (r= -.353, DF=645,
p=000), inhalation (r=.430, Df=645, p=000) to rectal/vaginal (r=-.225, DF=645, p=000),
to outcome minor (r= -.222, DF=645, p=000), to major outcome (r= .266, Df=645,
p=000), to discharge disposition ( r= -.274, DF=645, p=000), admitted disposition
(r=.181, DF=645, p=000), exposure to medication and pharmaceutical products (r=-.353,
DF=645, p=000), to recreational drugs (r=283, DF=645, p=000), suicidal category of
exposure (r= -.258, DF=645, p=000).
TABLE 5: Significant correlations with cocaine poisoning.
Variable 1

Cocaine
poisoning

Variable 2

R

DF

Inhalation

.430

645

p
Value
.0001

Major outcome

.266

645

.0001

Chest pain
History of drug abuse
Age
History of Illicit drug abuse
Unresponsiveness
Hospital admission

.507
.245
.227
.283
-.234
.181

645
645
645
645
645
645

.0001
.0001
.0001
.0001
.0001
.0001

Antidep/antipsych

.173

645

.0001

Prescription medications

-.353

645

.0001
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6.0. PREDICTION ANALYSIS
One of the interests in this study is to determine predictors for the final outcome
of ED poisoning, which could be useful for improving patients’ management and also in
implementing preventive measures. Predictors for poisoning final outcome, asthma, and
for the risk of suicide in our population were computed using regression analysis.
The stepwise regression analysis for outcome resulted in the construction of the
following models.
Final Outcome of Poisoning = 0.108 + 0.200 * Cocaine + 0.114 * Inhalation + 0.121 *
CVD + 0.103 * Asthma + 0.94 * Gender + 0. 09 * Prior Poisoning History

Cocaine was the most predictive for the major outcome of poisoning, route of
inhalation was the second most important predictor. Cardiovascular diseases were third,
asthma, gender and prior history of poisoning.
Stepwise regression analysis was also run to compute predictors for the risk of
suicide attempts using poison. Predictors’ intercept and coefficient, as well as the
significance of the overall model and the individual models produced, as well as the
regression assumptions described in addendum 1. Measures of association are expressed
in the following mathematical formula:
Model (Suicide) = 0.394 +0.330 *Depression -0.005* Age -0.99* Gender+ 0.072* Prior
poisoning history-0.055-0.082*unemployed

Depression is the greatest risk factor for suicide attempts; age and gender, prior
poisoning event, and employment were also significantly correlated to suicide, and
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remarkably, psychotic disorders, though known for their possible risk for suicide,
particularly, in younger schizophrenics, our data did not support this assumption.
A stepwise regression was performed for both asthma as a dependant variable and
heroin as an independent with the assumption that heroin affects asthma and exacerbates
it. The measure of association was expressed in the following mathematical formula:
Model (Asthma) = 0/419 + 0.221 *Inhalation + 0.147 Prior Poisoning History. -0.140 *
Gender + 0.149 * Heroin + 0.728 Cancer + 0.136 * Race_AA – 0.004 * Age
Again, inhalation is the greatest predictor of asthma with prior history of abuse,
heroin, gender, age, and race of African American being the most other important
predictors for asthma (Table 9, Table 10).
Similarly, another regression was run and asthma was the independent variable to
check on the assumption that asthma predisposes patients to abusing heroin. The measure
of association is expressed in the following formula:
Model (Heroin) = 0.284 + 0.794* Rectal/Vaginal route + 0.142* Asthma + 0.273 *
Inhalation + 0.394*Injection – 0.193* CVD – 0.110* Prior documented Poisoning
history – 0.077* Alcohol + 0.111 * Psychosis

Asthma was second strongest heroin abuse predictor (Table 3, Figure 41, 42, 43).
This could also be that the observed correlation might indicate asthma is predisposing
heroin addiction, or at least that the overall association is just a mixed effect from both
variables in both directions. Inhalation is also a predictor of heroin abuse.
Rectal and vaginal route of drug use is also very prevalent in heroin abusers. Psychosis is
also a predictor of heroin abuse, which supports the study’s third hypothesis.
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DISCUSSION

Poisoning in the emergency department is still a problem, especially when it
relates to the use of recreational drugs. The magnitude of this problem has been explained
elsewhere, however its implications in ED, have been actively illustrated in this
investigation.
In exploring the relationship between asthma and heroin, our data revealed that
there are two other significantly correlated co-morbidities with drug abuse, particularly
chronic hypertension and cardiovascular diseases that were correlated to cocaine use. In
reviewing the literature, we were unable to find any evidence of similar correlations,
though, in our study it was found to be strongly correlated (r= .220, DF=745, p=.0001)
for hypertension and (r= .227, DF=645, p=0001) for cardio vascular diseases. While the
relationship of asthma to drug abuse is complicated, and many authors have suggested
numerous theories to explain how heroin correlates to asthma, hypertension correlation to
cocaine might be due to a more direct effect of cocaine on vessels. In fact, cocaine was
extensively studied, especially its effect on enzymatic modulation and its ability to affect
the fate of cell necrosis and apoptosis in the liver (Harbison et al., 2003, Harbison et al.
2000, Price et al. 1999). Cocaine has also been shown to have numerous other effects on
the cell signaling system and on the vascular bed by modifying the peripheral resistance
and inducing a potent vasospasm that raises the blood pressure and increases the cardiac
output. The vasopressor effects of cocaine are mostly mediated by norepinephrine of
sympathetic nervous system (Hollander et al. 2008). By the same mechanism, cocaine
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induces a vasoconstriction in coronary vessels and results in chest pain that mimics
unerringly an angina or a myocardial infarct. Cocaine abusers may present chest pain
similar to angina or coronary infarct which could result in a hospitalization. On
discharge, a patient will generally be categorized as having a history of chest pain that
will be documented in the patient’s medical history but without any mention of its
temporal relationship to cocaine. This type of documentation might have interfered with a
more accurate heart assessment and resulted in significant misclassification of cases in
the cardiovascular diseases group. As a result, an apparent correlation of cocaine to heart
disease might have been seen as a result of this misclassification. In summary, the
apparent correlation of hypertension to cocaine might just be due to the direct effect of
cocaine on the vasculature and in the case of cardiovascular disease and it seems that
some of these cardio vascular co morbidities that were captured were partially, if not
totally, cocaine-related diagnoses
In a study conducted in ED to assess the prevalence of cocaine use in patients
with hypertension who presented to ED for complaints not related to cocaine use, the
author reported that only 13% of the total 99 cases of hypertension tested positive for
cocaine, and 38% of them presented for chest pain or for congestive heart failure and
were prescribed beta-adrenergic antagonist medications. In our series, the prevalence of
cocaine admissions among hypertension patients was 47.2% (n=94) which is higher
compared to what was previously reported.
As a result of the high prevalence rate of heroin and cocaine use in our
population, it is unlikely that patients who have underreported their drug use have
affected the results of our study. The higher prevalence of drug use cannot be explained
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by over reporting because patients are more likely to underreport than to over-report the
use of controlled substances. However, even if they have underreported, one would
expect our observed difference to be even larger. Thus, if any drug controlled user was
incorrectly misclassified into a non-user group rather than a user group, our results would
be expected to show a higher difference.
Many cases were reported in recent years in relation to sudden and severe asthma
incidents that were temporally correlated to the abuse of cocaine and heroin, and
numerous authors report this relationship. They further conclude that heroin may be
triggering asthma attacks and that heroin associated withy status asthmaticus. Another
study reviewed death reports in the state of Maryland and demonstrated that a high
percentage of patients who died from asthma had also abused drugs and their post
mortem urine drug tests were positive (Weitzman et al.).
Over 4% of all admissions for asthma in the US require mechanical ventilation,
though there is still controversy regarding the optimal treatment for severe asthma
requiring intensive care optimal intubations; some authors have also reported that many
of the asthma patients requiring intubations are heroin abusers.
Asthma patients, it seems, tend to use various drugs for abuse, and both legal and
illicit drugs were described to be abused by asthma patients, including illegal inhalers
(Thompson et al., 1983) and prescription drugs (including the ones that were not widely
used by others such as glucorticoids, and inhalers salbutamol) (Kinirons, 1983. Quddusi
et al. 1998). There was also a study conducted that was designed to compare tobacco and
alcohol use in asthmatic students to non-asthmatics. This study found that high school
students with current asthma used cigarettes, cigars, marijuana, and inhalants (huffing) at
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rates greater than high school students without current asthma (Boyd et al. 2006; Jones et
al. 2006). It appears that asthma patients are subject to higher abuse susceptibility; this
might be due to many reasons. The high anxiety of asthmatics could drive asthma patient
to reduce their level of anxiety by abusing various drugs. There is still much to know
about asthma co-morbidities, in particular its associated behavioral changes and effect on
patients’ psychological well being. Recently Blackman et al. (2007) reported that
children with asthma have higher rates of attention deficit/hyperactivity disorders;
diagnoses of depression, behavioral disorders, learning disabilities, and missed school
days. Behavioral changes were also seen in the adult population, and the effect on asthma
management has always been a concern for increased morbidity and mortality in asthma.
(Volicer et al. 2006). Moreover, there is evidence that drug dependence can run in
families and that a person's genetic makeup can affect how the body processes a drug,
and could also determine the drug's effect. These individual differences can make some
people more likely to use drugs and to become dependent upon them.
Due to its prospect in therapeutic and its role as an analgesic, heroin’s mode of
action and mechanism of abuse and dependence has been heavily studied; particularly its
genetic aspect where basic animal research and human studies have shown that complex
genetic mediators exist, many gene and receptors are implicated in this behavioral aspect
of heroin addiction. (Xuei et al., 2007)
The relationship between asthma and heroin poisoning has been seen in previous
reports from an asthma management point of view; heroin and asthma were observed to
be temporally related. It was then concluded that heroin exacerbates asthma but a
mechanism could not be established. Though this approach seems simple but logical,
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researchers are skeptical of a receptor mediated effect on the bronchus as opiates favor
blocking bronchoconstriction through these receptors instead of stimulating it.
Researchers have also argued that the heroin effect on bronchoconstriction might occur
through a non-receptor mediated mechanism that might also potentiated by an
inflammatory response. No supporting evidence has been produced regarding this theory
other than heroin may deregulate mast cells and release histamine.
Depression has been described in the literature as a risk factor for poisoning
because of the suicidal tendency that generally accompanies depressed patients. Our data
has reinforced this belief and illustrated a strong relationship between suicidal intent
using poison. Suicidal intent was found to be positively correlated (r=.453), which
statistically translate into an r squared that is equal to .205. This value may be described
as: over 20% of suicide events seen in ED were attributed to this preexisting depression.
Though depression as a risk factor has been previously reported, little description of the
magnitude of the depression contributes in causing patients to commit suicide using
poison. In our series, and according to our data, this component was estimated to 20.5%.
It is known that there are certain triggers, for depressed patients with suicidal
thoughts, which intensify suicidal urges. The question that remains unanswered is how
much drug addiction is related to the modification, intensification, or renewal of suicidal
triggers in comparison to non-addicted, depressed or psychotic patients. How much
impact does drug addiction have on decision capabilities regarding self harming,
assuming that he or she is in fact under extremely high stress from his or her need for
drugs, and additional stress that originates from his or her depressed mood or psychotic
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illusion. If that is the case, what determines the patient’s behavior in choosing the dose,
the method, and the timing for shifting from intent to action?
In this study, psychotic disorders were also identified as being significantly
correlated with suicide attempts, but the coefficient of significance was relatively smaller
than the one seen in depression. The Pearson’s coefficient was r =.163 which translates to
only 2.6% of suicidal effect that can be attributable to preexisting psychotic disorders.
However, another correlation was also established between psychosis and the use of antipsychotic and anti-depressors that could indicate that patients with psychotic disorders
are subject to the risk of auto intoxicating themselves by using their own prescription
medication. A similar pattern was seen in patients with depression that are under tricyclic
medication, but this scenario is even more complicated with anti-depressors given the
fact that these medications have a very narrow safety window, and many depressed
patients overdose unintentionally. Patient education regarding tricyclic toxicity has
become routine now after all the accidents that were seen in ED. Moreover, the current
recommended best practice is to limit the prescription of tricyclics antidepressants in
favor of the newer selective serotonin reuptake inhibitors (SSRI).
Poisoning and drug addiction remain a significant burden on the healthcare
system, particularly on the asthmatic. Our follow up cost study was designed to compare
asthmatics with a history of drug addiction and poisoning to another group of asthmatics
without any history of drug poisoning or addiction. Both groups were compared with
respect to length of stay (LOS) inpatient, age, gender, and expenditures. The mean LOS
for asthmatics without drug abuse was 1.21 days and a SD of .695, and for the asthmatic
patient with history of illicit drug poisoning of 7.07 days. The hospital charges ranged
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between $99.00 and $18096.00 with a mean of $2941 for asthmatic without abuse and
between $52.00 and $695874.00 with a mean of $28028.00 for the group of asthmatics
with illicit drug poisoning. A significant difference was established (p<.001) between the
LOS of asthma with heroin and/or cocaine abuse as compared to LOS of asthma without
abuse, and a significant difference in hospital cost was also established between the 2
groups (p< .0001.).
There are several potential limitations to this study. The study is retrospective and
the information was collected from the patients’ charts, which varied in accuracy and
availability between cases. Due to the high rates of drug abuse history, it does not seem
that this study underestimated the abuse; however it might have underestimated some comorbidity such as arthritis, and particularly depression, which is still not screened
systematically for every patient visiting ED, especially in a setting of drug overdose
emergencies. Another potential limitation of this study was that there was no way for the
study to follow up on specific cases and screen patients for suicidal ideation to find out if
they have had any intent for self-harm.
One of the other limitations to this study is inherent to case capture, given the
initial design that did not take in consideration the complexity of the coding process.
Unfortunately this issue was discovered after the data collection started; in fact cases like
alcohol poisoning were not coded under poisoning, but under abuse, and similarly,
marijuana use was not captured under poisoning, but under a separate code. In the case of
alcohol and marijuana use, our study has accounted mainly for events with overdose that
resulted in significant effects. Similarly, adverse drug reaction and therapeutic poisoning
were not coded under poisoning unless they resulted in a significant effect. The study aim
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was not adverse reaction, marijuana or alcohol abuse, which was the reason why these
deficiencies did not affect the validity of the study results nor its ability to be generalized.
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CONCLUSION

In conclusion, the findings of this research supported the hypothesis that drug
abuse is the greatest risk factor for poisoning in the emergency department over
prescription drugs, environmental and occupational exposures. This research has shown
that there is correlation between chronic diseases and intentional poisoning using illicit
drugs, in particular cocaine and heroin. This study has also shown a correlation between
chronic hypertension and cocaine, cardiovascular diseases and cocaine, and a correlation
between asthma and heroin abuse. Our data has verified that there is an ongoing change
in illicit drug route of intake that is shifting from injection to inhalation; expectantly this
shift will have a positive effect on reducing the prevalence of HIV and hepatitis B in the
future. However, it seems that the heavy use of illicit drugs through inhalation has
resulted in novel problems to asthma patients. A measure of association was established
between asthma and heroin use, and inhalation was found to be the greatest predictor for
asthma in this population.
The results suggest that suicidal behaviors are not infrequent occurrences among
drug users, and that they often coexist and complicate other medical conditions.
Predictors for suicide attempts were produced, and it was determined that interventions
designed to reduce suicidal behaviors should simultaneously address preexisting medical
conditions that could predispose or increase the patient’s risk for transitioning from
ideation to action. Rates of depression and associated psychotic disorders in drug addicts
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with asthma indicates a need to systematically screen young and middle aged adults with
asthma and drug abuse for depression and for suicide risk.
This study provides evidence supporting the idea that heroin and cocaine abuse
are serious issues that significantly raise the cost of asthma and increase both the rate of
hospitalization and hospital LOS. Pragmatic guidelines and innovations in reducing
heroin and cocaine abuse in patients with asthma may improve the severity of the disease,
and reduce its burden on the healthcare system and on society.
This research was able to characterize the circumstances of incidents of poisoning
and provide a greater understanding of the extent of this problem and its burden on
patients and on society. It has also identified numerous predictors that can be used by
healthcare organizations, practitioners, and health policy makers for improving the
management of asthma and its complications that result from drug use. This study has
helped in consolidating a considerable amount of information on co-morbidity, drug use,
smoking and alcohol prevalence that may be very useful for patient management and
future research.
Drug abuse is a burden on asthma patients, particularly those that are not covered
by insurance. Asthma education and self-management techniques in patients
acknowledging the use of recreational drugs, specifically heroin or cocaine by
insufflations, need to be provided and patients must be informed about the potential risk
and educated on how to prevent significant asthma exacerbation by avoiding common
triggers, drug use, and other additional stress. Enrollment of asthma patients in free drug
rehabilitation programs may be the way of the future; these programs can be sponsored
by the state or by insurance companies. Similar programs will cut down significantly on
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asthma costs that are still a top public health concern in many states such as the state of
Illinois. The magnitude of loss from the additional burden that poisoning is placing on the
society and on insurance companies, as well as on asthmatics, can be minimized if similar
steps were taken.
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APPENDIX A: MODELS CALCULATION TABLES

TABLE 6: Model Summary for Poisoning Final Outcome
Model
6

Sum of Squares df

Mean Square

F

Sig.

Regression

19.545

6

3.257

14.796

.000f

Residual

131.655

598

.220

Total

151.200

604

a. Predictors: (Constant), Cocaine
b. Predictors: (Constant), Cocaine, INHALATION
c. Predictors: (Constant), Cocaine, INHALATION, P_POISON_HIS
d. Predictors: (Constant), Cocaine, INHALATION, P_POISON_HIS,
CVD2
e. Predictors: (Constant), Cocaine, INHALATION, P_POISON_HIS, CVD2, ASTHMA2
f. Predictors: (Constant), Cocaine, INHALATION, P_POISON_HIS, CVD2, ASTHMA2,
Gender
g. Dependent Variable: OUTC_major
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TABLE 6 (Continued): Model

Summary for Poisoning Final Outcome

Coefficients
Standardized
Unstandardized Coefficients

Coefficients

B

Std. Error

Beta

(Constant)

.108

.070

Cocaine

.200

.047

INHALATION

.114

P_POISON_HIS

Model
6

t

Sig.

1.552

.121

.186

4.283

.000

.046

.111

2.489

.013

.090

.041

.089

2.215

.027

CVD2

.121

.052

.092

2.336

.020

ASTHMA2

.103

.042

.101

2.466

.014

Gender

.094

.039

.094

2.401

.017

Model for Final Outcome of Poisoning = 0.200*Cocaine + 0.114 * Inhalation + 0.121
* CVD + 0.103 * Asthma + 0.94 * Gender + 0.09 * Prior Poisoning History
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TABLE 7: Stepwise Regression Model Summary for Suicidal Predictability.
Model Summary

Mode R

R Square Adjusted R Std. Error of Change Statistics

l

Square

the Estimate

R

Square F

Change

Change

df1

df2

Sig.

F

Change

1

.453a

.206

.204

.304

.206

161.427 1

624

.000

2

.505b

.255

.253

.295

.050

41.508

1

623

.000

3

.519c

.269

.266

.292

.014

11.931

1

622

.001

4

.534

d

.285

.281

.289

.016

13.884

1

621

.000

5

.540

e

.291

.286

.288

.006

5.498

1

620

.019

6

.545f

.297

.290

.287

.006

5.085

1

619

.024

Coefficients
Unstandardized
Coefficients
Model
6

Standardized Coefficients

B

Std. Error

t

Sig.

.394

.074

5.285

.000

DEPRESSION2 .330

.028

.398

11.617

.000

Age

-.005

.001

-.195

-5.656

.000

Gender

-.099

.024

-.144

-4.149

.000

PP.doc.his

.072

.024

.104

2.962

.003

ASTHMA2

-.055

.024

-.079

-2.256

.024

unemployed

-.082

.036

-.077

-2.255

.024

(Constant)

Beta

Predictors Model (Suicide) = 0.394 +0.330 *Depression - 0.005* Age -0.99* Gender +
0.072* Prior poisoning history - 0.055 -0.082*unemployed.

92

TABLE 8: Heroin poisoning Predictors Model Summary
Model Summary

Change Statistics
Adjusted
Model R

R Std. Error of R

Square

Sig.

F

R Square

Square

the Estimate

Change

F Change

df1

df2

Change

1

.351a

.123

.122

.449

.123

87.441

1

624

.000

2

.423b

.179

.176

.434

.056

42.557

1

623

.000

3

.461c

.212

.209

.426

.033

26.366

1

622

.000

4

.500d

.250

.245

.416

.037

30.942

1

621

.000

5

.523e

.273

.267

.410

.023

19.940

1

620

.000

6

.531f

.281

.274

.408

.008

7.152

1

619

.008

7

.537g

.288

.280

.406

.007

5.968

1

618

.015

8

.542h

.294

.285

.405

.005

4.800

1

617

.029

TABLE 8: (Continued)
a. Predictors: (Constant), RECTAL_VAGINAL
b. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2
c. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION
d. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION
e. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION,
CVD2
f. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION, CVD2,
PP.doc.his
g. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION, CVD2, PP.doc.his,
h. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION, CVD2, PP.doc.his,
Dependent Variable: Heroin
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TABLE 8 (Continued): Heroin poisoning Predictors ANOVA and Model Coefficients
ANOVAi
Mean
Model

Sum of Squares df

F

Sig.

Square

8

Regression

42.078

8

5.260

Residual

101.141

617

.164

Total

143.220

625

32.087 .000h

Model Coefficientsa
Standardized
Unstandardized Coefficients
Coefficients

Model

t

Sig.

3.576

.000

B

Std. Error

.284

.079

.793

.061

.511

13.019

.000

ASTHMA2

.142

.035

.146

4.060

.000

INHALATION

.273

.043

.278

6.414

.000

INJECTION

.394

.080

.183

4.896

.000

CVD2

-.193

.043

-.153

-4.484

.000

PP.doc.his

-.110

.035

-.113

-3.110

.002

ETOH2

-.077

.033

-.080

-2.306

.021

PSYCH2

-.111

.051

-.075

-2.191

.029

(Constant)

Beta

RECTAL_VAGIN
AL

8

a. Dependent Variable: Heroin
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Model (Heroin) = 0.284 + 0.793* Rectal/Vaginal route + 0.142* Asthma + 0.273 *
Inhalation + 0.394*Injection – 0.193* CVD – 0.110* Prior documented Poisoning
history – 0.077* Alcohol – 0.111 * Psychosis

TABLE 9: Asthma Model Predictors.
A NOVA
Sum
Squares

df

Mean
Square

F

Sig.

Regression 28.212

10

2.821

14.007

.000l

Residual

124.674

619

.201

Total

152.886

629

Model

of

a. Predictors: (Constant), INHALATION
b. Predictors: (Constant), INHALATION, P_POISON_HIS
c. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine
d. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender
e. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA
f. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA,
Hist.D.A
g. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA,
Hist.D.A, DERMAT
h. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA,
Hist.D.A, DERMAT, Age
i. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA,
Hist.D.A, DERMAT, Age, DIABETES
j. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA,
Hist.D.A, DERMAT, Age, DIABETES2, Heroin
k. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, RACE_AA, Hist.D.A,
DERMAT, Age, DIABETES2, Heroin
l. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, RACE_AA, Hist.D.A,
DERMAT, Age, DIABETES2, Heroin, RECTAL_VAGINAL
m. Dependent Variable: ASTHMA2
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TABLE 10: Asthma Regressions’ Model Summary.
Model Summary
Mode
R
l

R Square

Adjusted
Square

R

Std. Error of the Estimate

1

.242a

.059

.057

.480

2

b

.304

.092

.090

.472

3

.336c

.113

.109

.467

4

.365d

.133

.128

.462

5

.390e

.152

.145

.457

6

.401f

.161

.153

.455

7

g

.169

.160

.453

.411
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TABLE 10 (Continued): Asthma Regression Model Summary.
a. Predictors: (Constant), INHALATION
b. Predictors: (Constant), INHALATION, P_POISON_HIS
c. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender
d. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, Heroin
e. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, Heroin, CANCER2
f. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, Heroin, CANCER2,
RACE_AA
g. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, Heroin, CANCER2,
RACE_AA, Age
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TABLE 10 (Continued) Asthma Regression Model’s coeifficients.
h. Dependent Variable: ASTHMA
Coefficientsa
Unstandardized
Coefficients

Standardized
Coefficients

B

Std. Error

Beta

.419

.081

INHALATIO
.221
N

.040

.217

5.579 .000

P_POISON_H
.147
IS

.039

.147

3.815 .000

Gender

-.140

.037

-.141

-3.772 .000

Heroin

.149

.039

.143

3.841 .000

CANCER2

.728

.187

.143

3.884 .000

RACE_AA

.136

.045

.114

2.994 .003

Age

-.004

.001

-.096

-2.481 .013

Model

(Constant)

a.
Dependent
ASTHMA2

t

Sig.

5.158 .000

Variable:
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